JP5912529B2 - 1,4−ブタンジオールの生成のための微生物体 - Google Patents
1,4−ブタンジオールの生成のための微生物体 Download PDFInfo
- Publication number
- JP5912529B2 JP5912529B2 JP2011526949A JP2011526949A JP5912529B2 JP 5912529 B2 JP5912529 B2 JP 5912529B2 JP 2011526949 A JP2011526949 A JP 2011526949A JP 2011526949 A JP2011526949 A JP 2011526949A JP 5912529 B2 JP5912529 B2 JP 5912529B2
- Authority
- JP
- Japan
- Prior art keywords
- coa
- bdo
- hydroxybutyryl
- dehydrogenase
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 title claims description 184
- 238000004519 manufacturing process Methods 0.000 title claims description 88
- 244000005700 microbiome Species 0.000 title claims description 55
- 102000004190 Enzymes Human genes 0.000 claims description 257
- 108090000790 Enzymes Proteins 0.000 claims description 257
- 230000037361 pathway Effects 0.000 claims description 234
- 230000000813 microbial effect Effects 0.000 claims description 188
- 238000000034 method Methods 0.000 claims description 165
- 230000015572 biosynthetic process Effects 0.000 claims description 131
- 238000006243 chemical reaction Methods 0.000 claims description 128
- 150000007523 nucleic acids Chemical class 0.000 claims description 127
- 108020004707 nucleic acids Proteins 0.000 claims description 120
- 102000039446 nucleic acids Human genes 0.000 claims description 120
- 101710088194 Dehydrogenase Proteins 0.000 claims description 109
- 108090000854 Oxidoreductases Proteins 0.000 claims description 102
- BAMBWCGEVIAQBF-CITAKDKDSA-N 4-hydroxybutyryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCO)O[C@H]1N1C2=NC=NC(N)=C2N=C1 BAMBWCGEVIAQBF-CITAKDKDSA-N 0.000 claims description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 claims description 15
- 238000012258 culturing Methods 0.000 claims description 14
- CRFNGMNYKDXRTN-CITAKDKDSA-N butyryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CRFNGMNYKDXRTN-CITAKDKDSA-N 0.000 claims description 12
- PIAOXUVIBAKVSP-UHFFFAOYSA-N γ-hydroxybutyraldehyde Chemical compound OCCCC=O PIAOXUVIBAKVSP-UHFFFAOYSA-N 0.000 claims description 12
- OJFDKHTZOUZBOS-CITAKDKDSA-N acetoacetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OJFDKHTZOUZBOS-CITAKDKDSA-N 0.000 claims description 9
- 108030005660 3-hydroxybutyryl-CoA dehydratases Proteins 0.000 claims description 8
- 108010055682 3-hydroxybutyryl-CoA dehydrogenase Proteins 0.000 claims description 7
- 102100039894 Hemoglobin subunit delta Human genes 0.000 claims description 7
- 108010093991 Vinylacetyl-CoA Delta-isomerase Proteins 0.000 claims description 7
- 108010035023 4-hydroxybutyryl-CoA dehydratase Proteins 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 4
- KFWWCMJSYSSPSK-PAXLJYGASA-N crotonoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 KFWWCMJSYSSPSK-PAXLJYGASA-N 0.000 claims description 3
- 229920001791 ((R)-3-Hydroxybutanoyl)(n-2) Polymers 0.000 claims 2
- QHHKKMYHDBRONY-RMNRSTNRSA-N 3-hydroxybutanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QHHKKMYHDBRONY-RMNRSTNRSA-N 0.000 claims 2
- 108090001042 Hydro-Lyases Proteins 0.000 claims 2
- 102000004867 Hydro-Lyases Human genes 0.000 claims 2
- UATIGEHITDTAGF-CITAKDKDSA-N vinylacetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC=C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 UATIGEHITDTAGF-CITAKDKDSA-N 0.000 claims 2
- 108010036467 butanediol dehydrogenase Proteins 0.000 claims 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 399
- 229940088598 enzyme Drugs 0.000 description 235
- 108090000623 proteins and genes Proteins 0.000 description 190
- 239000000047 product Substances 0.000 description 124
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 99
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 97
- 239000005516 coenzyme A Substances 0.000 description 97
- 229940093530 coenzyme a Drugs 0.000 description 97
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 97
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 93
- 102000004316 Oxidoreductases Human genes 0.000 description 86
- 230000000694 effects Effects 0.000 description 85
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 72
- 239000000758 substrate Substances 0.000 description 71
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 71
- 210000004027 cell Anatomy 0.000 description 68
- 230000002503 metabolic effect Effects 0.000 description 63
- ZSLZBFCDCINBPY-ZSJPKINUSA-N Acetyl-CoA Natural products O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 60
- 238000000855 fermentation Methods 0.000 description 59
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 58
- 230000004151 fermentation Effects 0.000 description 58
- 241000588724 Escherichia coli Species 0.000 description 57
- 102000004357 Transferases Human genes 0.000 description 56
- 108090000992 Transferases Proteins 0.000 description 56
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 51
- 150000001875 compounds Chemical class 0.000 description 50
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 47
- 230000001419 dependent effect Effects 0.000 description 46
- 230000014509 gene expression Effects 0.000 description 46
- 239000008103 glucose Substances 0.000 description 46
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 44
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 44
- 102000004169 proteins and genes Human genes 0.000 description 44
- 239000000243 solution Substances 0.000 description 44
- 108010084086 Succinate-Semialdehyde Dehydrogenase Proteins 0.000 description 43
- 102000005566 Succinate-Semialdehyde Dehydrogenase Human genes 0.000 description 43
- 230000006870 function Effects 0.000 description 42
- 230000012010 growth Effects 0.000 description 41
- 238000000926 separation method Methods 0.000 description 41
- VNOYUJKHFWYWIR-ITIYDSSPSA-N succinyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VNOYUJKHFWYWIR-ITIYDSSPSA-N 0.000 description 41
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 40
- 235000018102 proteins Nutrition 0.000 description 39
- 230000004048 modification Effects 0.000 description 35
- 238000012986 modification Methods 0.000 description 35
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 34
- 102000003960 Ligases Human genes 0.000 description 33
- 108090000364 Ligases Proteins 0.000 description 33
- 102000004157 Hydrolases Human genes 0.000 description 31
- 108090000604 Hydrolases Proteins 0.000 description 31
- 239000002609 medium Substances 0.000 description 31
- 241000894007 species Species 0.000 description 31
- 239000001384 succinic acid Substances 0.000 description 31
- 108090000340 Transaminases Proteins 0.000 description 30
- 239000000543 intermediate Substances 0.000 description 30
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 29
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 29
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 29
- 102000014898 transaminase activity proteins Human genes 0.000 description 29
- 239000000126 substance Substances 0.000 description 28
- UIUJIQZEACWQSV-UHFFFAOYSA-N succinic semialdehyde Chemical compound OC(=O)CCC=O UIUJIQZEACWQSV-UHFFFAOYSA-N 0.000 description 28
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 27
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 26
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 25
- 150000001299 aldehydes Chemical class 0.000 description 25
- 239000000203 mixture Substances 0.000 description 25
- MMTYWJNSFWVPPS-UHFFFAOYSA-N 5-hydroxy-2-oxopentanoic acid Chemical compound OCCCC(=O)C(O)=O MMTYWJNSFWVPPS-UHFFFAOYSA-N 0.000 description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- -1 for example Chemical class 0.000 description 21
- 238000003786 synthesis reaction Methods 0.000 description 21
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 20
- 230000009615 deamination Effects 0.000 description 20
- 238000006481 deamination reaction Methods 0.000 description 20
- 238000005984 hydrogenation reaction Methods 0.000 description 20
- 108010021680 2-oxoglutarate decarboxylase Proteins 0.000 description 19
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 19
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 19
- 108010075728 Succinate-CoA Ligases Proteins 0.000 description 19
- 102000011929 Succinate-CoA Ligases Human genes 0.000 description 19
- 238000013459 approach Methods 0.000 description 19
- 230000001851 biosynthetic effect Effects 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 18
- 238000013461 design Methods 0.000 description 18
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 18
- 238000006722 reduction reaction Methods 0.000 description 18
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 17
- 229910052799 carbon Inorganic materials 0.000 description 17
- 230000009467 reduction Effects 0.000 description 17
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 16
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 16
- 239000000376 reactant Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 230000035772 mutation Effects 0.000 description 15
- 230000026731 phosphorylation Effects 0.000 description 15
- 238000006366 phosphorylation reaction Methods 0.000 description 15
- 238000004088 simulation Methods 0.000 description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 14
- 102000004031 Carboxy-Lyases Human genes 0.000 description 14
- 108090000489 Carboxy-Lyases Proteins 0.000 description 14
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 14
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 14
- 238000006114 decarboxylation reaction Methods 0.000 description 14
- 239000012634 fragment Substances 0.000 description 14
- 101150109249 lacI gene Proteins 0.000 description 14
- 239000006225 natural substrate Substances 0.000 description 14
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 14
- 239000013598 vector Substances 0.000 description 14
- 229940006015 4-hydroxybutyric acid Drugs 0.000 description 13
- 238000006241 metabolic reaction Methods 0.000 description 13
- 239000003960 organic solvent Substances 0.000 description 13
- 239000002028 Biomass Substances 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000037430 deletion Effects 0.000 description 12
- 238000012224 gene deletion Methods 0.000 description 12
- 229930195712 glutamate Natural products 0.000 description 12
- 238000000126 in silico method Methods 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 239000002243 precursor Substances 0.000 description 12
- BLFRQYKZFKYQLO-UHFFFAOYSA-N 4-aminobutan-1-ol Chemical compound NCCCCO BLFRQYKZFKYQLO-UHFFFAOYSA-N 0.000 description 11
- HHFBTTVZSVBPFP-CITAKDKDSA-N 4-aminobutanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCN)O[C@H]1N1C2=NC=NC(N)=C2N=C1 HHFBTTVZSVBPFP-CITAKDKDSA-N 0.000 description 11
- 108010093796 4-hydroxybutyrate dehydrogenase Proteins 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 11
- 241000193401 Clostridium acetobutylicum Species 0.000 description 11
- 150000001720 carbohydrates Chemical class 0.000 description 11
- 235000014633 carbohydrates Nutrition 0.000 description 11
- 239000003054 catalyst Substances 0.000 description 11
- 238000010276 construction Methods 0.000 description 11
- 230000002950 deficient Effects 0.000 description 11
- 238000012217 deletion Methods 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 10
- 238000007792 addition Methods 0.000 description 10
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 10
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 238000004364 calculation method Methods 0.000 description 10
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 10
- 230000004060 metabolic process Effects 0.000 description 10
- 239000000178 monomer Substances 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 102000001253 Protein Kinase Human genes 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- 239000011942 biocatalyst Substances 0.000 description 9
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 9
- 230000001939 inductive effect Effects 0.000 description 9
- 230000003834 intracellular effect Effects 0.000 description 9
- 238000005457 optimization Methods 0.000 description 9
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- 229920001184 polypeptide Polymers 0.000 description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 230000002441 reversible effect Effects 0.000 description 9
- VHKNBDIQDAXGBL-UHFFFAOYSA-N 2,5-dioxopentanoic acid Chemical compound OC(=O)C(=O)CCC=O VHKNBDIQDAXGBL-UHFFFAOYSA-N 0.000 description 8
- OQEBBZSWEGYTPG-UHFFFAOYSA-N 3-aminobutanoic acid Chemical compound CC(N)CC(O)=O OQEBBZSWEGYTPG-UHFFFAOYSA-N 0.000 description 8
- QYHKIXYHXCJHTR-CITAKDKDSA-N 5-[2-[3-[[(2r)-4-[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-4,5-dioxopentanoic acid Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C(=O)CCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QYHKIXYHXCJHTR-CITAKDKDSA-N 0.000 description 8
- 108700024126 Butyrate kinases Proteins 0.000 description 8
- MOABGIHEYKQZPV-XXXNBSBMSA-N CC(=O)CC(O)=O.O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 Chemical compound CC(=O)CC(O)=O.O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MOABGIHEYKQZPV-XXXNBSBMSA-N 0.000 description 8
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 150000001413 amino acids Chemical group 0.000 description 8
- 230000010261 cell growth Effects 0.000 description 8
- 235000013922 glutamic acid Nutrition 0.000 description 8
- 239000004220 glutamic acid Substances 0.000 description 8
- 238000000622 liquid--liquid extraction Methods 0.000 description 8
- 230000037353 metabolic pathway Effects 0.000 description 8
- 108060006633 protein kinase Proteins 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 238000000638 solvent extraction Methods 0.000 description 8
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 8
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 7
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 7
- 108091000080 Phosphotransferase Proteins 0.000 description 7
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 7
- 238000004821 distillation Methods 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000007791 liquid phase Substances 0.000 description 7
- 239000002207 metabolite Substances 0.000 description 7
- 229930182817 methionine Natural products 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 102000020233 phosphotransferase Human genes 0.000 description 7
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 7
- TYEYBOSBBBHJIV-UHFFFAOYSA-N 2-oxobutanoic acid Chemical compound CCC(=O)C(O)=O TYEYBOSBBBHJIV-UHFFFAOYSA-N 0.000 description 6
- KDVFRMMRZOCFLS-UHFFFAOYSA-N 2-oxopentanoic acid Chemical compound CCCC(=O)C(O)=O KDVFRMMRZOCFLS-UHFFFAOYSA-N 0.000 description 6
- 101710094518 4-aminobutyrate aminotransferase Proteins 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- 101150116295 CAT2 gene Proteins 0.000 description 6
- 101100326920 Caenorhabditis elegans ctl-1 gene Proteins 0.000 description 6
- 241000186570 Clostridium kluyveri Species 0.000 description 6
- 108020002908 Epoxide hydrolase Proteins 0.000 description 6
- CZWARROQQFCFJB-UHFFFAOYSA-N L-2-Amino-5-hydroxypentanoic acid Chemical compound OC(=O)C(N)CCCO CZWARROQQFCFJB-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 101100126846 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) katG gene Proteins 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 241000589776 Pseudomonas putida Species 0.000 description 6
- 101710181816 Pyruvate-formate-lyase deactivase Proteins 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
- 239000006227 byproduct Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 239000012526 feed medium Substances 0.000 description 6
- 238000012239 gene modification Methods 0.000 description 6
- 230000005017 genetic modification Effects 0.000 description 6
- 235000013617 genetically modified food Nutrition 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000006680 metabolic alteration Effects 0.000 description 6
- 230000002018 overexpression Effects 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 5
- 108020004306 Alpha-ketoglutarate dehydrogenase Proteins 0.000 description 5
- 102000006589 Alpha-ketoglutarate dehydrogenase Human genes 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 102000005486 Epoxide hydrolase Human genes 0.000 description 5
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 5
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 5
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- 241000605862 Porphyromonas gingivalis Species 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 238000004422 calculation algorithm Methods 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000000205 computational method Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229960003136 leucine Drugs 0.000 description 5
- XGAWKWCCTIEGRI-UHFFFAOYSA-N phosphono 4-hydroxybutanoate Chemical compound OCCCC(=O)OP(O)(O)=O XGAWKWCCTIEGRI-UHFFFAOYSA-N 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 229910000160 potassium phosphate Inorganic materials 0.000 description 5
- 235000011009 potassium phosphates Nutrition 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 101150031436 sucD gene Proteins 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 5
- AECJCRHEUUKQRT-SJOXLDEWSA-N (2S)-2-amino-4-hydroxybutanoic acid [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate Chemical compound OC(=O)[C@@H](N)CCO.O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 AECJCRHEUUKQRT-SJOXLDEWSA-N 0.000 description 4
- TZBGSHAFWLGWBO-ABLWVSNPSA-N (2s)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-1h-pteridin-6-yl)methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](CCC(=O)OC)C(O)=O)=CC=C1NCC1NC(C(=O)NC(N)=N2)=C2NC1 TZBGSHAFWLGWBO-ABLWVSNPSA-N 0.000 description 4
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 4
- RMQJECWPWQIIPW-OWOJBTEDSA-N 4-hydroxy-crotonic acid Chemical compound OC\C=C\C(O)=O RMQJECWPWQIIPW-OWOJBTEDSA-N 0.000 description 4
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 108010092060 Acetate kinase Proteins 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 101100494773 Caenorhabditis elegans ctl-2 gene Proteins 0.000 description 4
- 241000193403 Clostridium Species 0.000 description 4
- 241000252867 Cupriavidus metallidurans Species 0.000 description 4
- 102000020018 Cystathionine gamma-Lyase Human genes 0.000 description 4
- 108010045283 Cystathionine gamma-lyase Proteins 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 101100112369 Fasciola hepatica Cat-1 gene Proteins 0.000 description 4
- 102100034013 Gamma-glutamyl phosphate reductase Human genes 0.000 description 4
- 101710198928 Gamma-glutamyl phosphate reductase Proteins 0.000 description 4
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 4
- 102000005133 Glutamate 5-kinase Human genes 0.000 description 4
- 108010016106 Glutamate-5-semialdehyde dehydrogenase Proteins 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- KABXUUFDPUOJMW-BYPYZUCNSA-N L-glutamic 5-semialdehyde Chemical compound OC(=O)[C@@H](N)CCC=O KABXUUFDPUOJMW-BYPYZUCNSA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 101100005271 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cat-1 gene Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 102100033073 Polypyrimidine tract-binding protein 1 Human genes 0.000 description 4
- FQFRDDVZPBFYST-CITAKDKDSA-N S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 4-hydroxybut-2-enethioate Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C=CCO)O[C@H]1N1C2=NC=NC(N)=C2N=C1 FQFRDDVZPBFYST-CITAKDKDSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
- 239000004473 Threonine Substances 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 101150014383 adhE gene Proteins 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 238000001952 enzyme assay Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 235000013882 gravy Nutrition 0.000 description 4
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 230000004952 protein activity Effects 0.000 description 4
- 150000003839 salts Chemical group 0.000 description 4
- 238000002741 site-directed mutagenesis Methods 0.000 description 4
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 4
- 229960000268 spectinomycin Drugs 0.000 description 4
- 238000000844 transformation Methods 0.000 description 4
- 108010024655 4-hydroxybutyrate CoA-transferase Proteins 0.000 description 3
- 101100536799 Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1) tgnE gene Proteins 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 108060006006 Cytochrome-c peroxidase Proteins 0.000 description 3
- 108020005199 Dehydrogenases Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010064571 Gene mutation Diseases 0.000 description 3
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 240000006024 Lactobacillus plantarum Species 0.000 description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 3
- 108060001084 Luciferase Proteins 0.000 description 3
- 239000007993 MOPS buffer Substances 0.000 description 3
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 3
- 102000016387 Pancreatic elastase Human genes 0.000 description 3
- 108010067372 Pancreatic elastase Proteins 0.000 description 3
- 244000057717 Streptococcus lactis Species 0.000 description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 229960003767 alanine Drugs 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 150000004716 alpha keto acids Chemical class 0.000 description 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 229940009098 aspartate Drugs 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- RNCXCPUOPDATPU-UHFFFAOYSA-N chromium(3+) oxocopper oxygen(2-) Chemical compound [O-2].[Cr+3].[Cu]=O.[O-2].[O-2].[Cr+3] RNCXCPUOPDATPU-UHFFFAOYSA-N 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000010924 continuous production Methods 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000009088 enzymatic function Effects 0.000 description 3
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 3
- 101150043302 gabD gene Proteins 0.000 description 3
- 238000002309 gasification Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 229960002989 glutamic acid Drugs 0.000 description 3
- 238000009904 heterogeneous catalytic hydrogenation reaction Methods 0.000 description 3
- 238000009905 homogeneous catalytic hydrogenation reaction Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000013028 medium composition Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 101150048333 ptb gene Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000002708 random mutagenesis Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 229940005605 valeric acid Drugs 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 229960004295 valine Drugs 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 2
- FGSBNBBHOZHUBO-UHFFFAOYSA-N 2-oxoadipic acid Chemical compound OC(=O)CCCC(=O)C(O)=O FGSBNBBHOZHUBO-UHFFFAOYSA-N 0.000 description 2
- XNIHZNNZJHYHLC-UHFFFAOYSA-N 2-oxohexanoic acid Chemical compound CCCCC(=O)C(O)=O XNIHZNNZJHYHLC-UHFFFAOYSA-N 0.000 description 2
- 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 2
- KPULXFNPTWGJQH-UHFFFAOYSA-N 3-hydroxy-4-oxo-4-propan-2-yloxybutanoic acid Chemical compound CC(C)OC(=O)C(O)CC(O)=O KPULXFNPTWGJQH-UHFFFAOYSA-N 0.000 description 2
- QHKABHOOEWYVLI-UHFFFAOYSA-N 3-methyl-2-oxobutanoic acid Chemical compound CC(C)C(=O)C(O)=O QHKABHOOEWYVLI-UHFFFAOYSA-N 0.000 description 2
- 108010060511 4-Aminobutyrate Transaminase Proteins 0.000 description 2
- DZQLQEYLEYWJIB-UHFFFAOYSA-N 4-aminobutanal Chemical compound NCCCC=O DZQLQEYLEYWJIB-UHFFFAOYSA-N 0.000 description 2
- 102100035923 4-aminobutyrate aminotransferase, mitochondrial Human genes 0.000 description 2
- 108030002957 Acetate CoA-transferases Proteins 0.000 description 2
- 241000193451 Acetoanaerobium sticklandii Species 0.000 description 2
- 108010006229 Acetyl-CoA C-acetyltransferase Proteins 0.000 description 2
- 102000005345 Acetyl-CoA C-acetyltransferase Human genes 0.000 description 2
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 2
- 102000006534 Amino Acid Isomerases Human genes 0.000 description 2
- 108010008830 Amino Acid Isomerases Proteins 0.000 description 2
- 108090000673 Ammonia-Lyases Proteins 0.000 description 2
- 102000004118 Ammonia-Lyases Human genes 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- 241000203069 Archaea Species 0.000 description 2
- 241001465318 Aspergillus terreus Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010071778 Benzoylformate decarboxylase Proteins 0.000 description 2
- 101001060691 Clostridium sporogenes (strain ATCC 7955 / DSM 767 / NBRC 16411 / NCIMB 8053 / NCTC 8594 / PA 3679) Aromatic 2-oxoacid reductase Proteins 0.000 description 2
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 241000195619 Euglena gracilis Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 108060002716 Exonuclease Proteins 0.000 description 2
- 108010074122 Ferredoxins Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 102100025413 Formyltetrahydrofolate synthetase Human genes 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- 241000588749 Klebsiella oxytoca Species 0.000 description 2
- 241001138401 Kluyveromyces lactis Species 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 101710159527 Maturation protein A Proteins 0.000 description 2
- 101710091157 Maturation protein A2 Proteins 0.000 description 2
- 108010047290 Multifunctional Enzymes Proteins 0.000 description 2
- 102000006833 Multifunctional Enzymes Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 241000589614 Pseudomonas stutzeri Species 0.000 description 2
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 2
- 102000013009 Pyruvate Kinase Human genes 0.000 description 2
- 108020005115 Pyruvate Kinase Proteins 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 2
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 101000716799 Sus scrofa Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Proteins 0.000 description 2
- 241000589499 Thermus thermophilus Species 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 238000005377 adsorption chromatography Methods 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 230000009604 anaerobic growth Effects 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008238 biochemical pathway Effects 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- JSHMCUNOMIZJDJ-UHFFFAOYSA-N butanoyl dihydrogen phosphate Chemical compound CCCC(=O)OP(O)(O)=O JSHMCUNOMIZJDJ-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 230000006652 catabolic pathway Effects 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 239000003245 coal Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000010205 computational analysis Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000001944 continuous distillation Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 210000000172 cytosol Anatomy 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000002900 effect on cell Effects 0.000 description 2
- 238000000909 electrodialysis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 102000013165 exonuclease Human genes 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 238000012246 gene addition Methods 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- 229960001867 guaiacol Drugs 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- FGKJLKRYENPLQH-UHFFFAOYSA-N isocaproic acid Chemical compound CC(C)CCC(O)=O FGKJLKRYENPLQH-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 150000004715 keto acids Chemical class 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 210000000633 nuclear envelope Anatomy 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 125000005522 oxopentanoic acid group Chemical group 0.000 description 2
- 238000005373 pervaporation Methods 0.000 description 2
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical compound OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 108010010718 poly(3-hydroxyalkanoic acid) synthase Proteins 0.000 description 2
- 229920000071 poly(4-hydroxybutyrate) Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 239000012808 vapor phase Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- TVYAJJQTTAXNFA-UHFFFAOYSA-N (4-nitrophenyl) 2-methyldecanoate Chemical compound CCCCCCCCC(C)C(=O)OC1=CC=C([N+]([O-])=O)C=C1 TVYAJJQTTAXNFA-UHFFFAOYSA-N 0.000 description 1
- GEWWCWZGHNIUBW-UHFFFAOYSA-N 1-(4-nitrophenyl)propan-2-one Chemical compound CC(=O)CC1=CC=C([N+]([O-])=O)C=C1 GEWWCWZGHNIUBW-UHFFFAOYSA-N 0.000 description 1
- OZHIYEINSCNALY-UHFFFAOYSA-N 1-aminobutan-1-ol Chemical compound CCCC(N)O OZHIYEINSCNALY-UHFFFAOYSA-N 0.000 description 1
- YNXICDMQCQPQEW-UHFFFAOYSA-N 1-naphthyl dihydrogen phosphate Chemical compound C1=CC=C2C(OP(O)(=O)O)=CC=CC2=C1 YNXICDMQCQPQEW-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- 108090000168 2-Oxoisovalerate Dehydrogenase (Acylating) Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UIKQNMXWCYQNCS-UHFFFAOYSA-N 2-hydroxybutanal Chemical compound CCC(O)C=O UIKQNMXWCYQNCS-UHFFFAOYSA-N 0.000 description 1
- VOKUMXABRRXHAR-UHFFFAOYSA-N 2-methyl-3-oxopropanoic acid Chemical compound O=CC(C)C(O)=O VOKUMXABRRXHAR-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- 108020003281 3-hydroxyisobutyrate dehydrogenase Proteins 0.000 description 1
- 102000006027 3-hydroxyisobutyrate dehydrogenase Human genes 0.000 description 1
- DBXBTMSZEOQQDU-UHFFFAOYSA-N 3-hydroxyisobutyric acid Chemical compound OCC(C)C(O)=O DBXBTMSZEOQQDU-UHFFFAOYSA-N 0.000 description 1
- 101710186512 3-ketoacyl-CoA thiolase Proteins 0.000 description 1
- 239000001388 3-methyl-2-oxobutanoic acid Substances 0.000 description 1
- OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
- CHDDAVCOAOFSLD-UHFFFAOYSA-N 3-phosphonopyruvic acid Chemical compound OC(=O)C(=O)CP(O)(O)=O CHDDAVCOAOFSLD-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- CNXHSMPAOQXDRE-BLPRJPCASA-N 4-aminobutanoic acid;[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3r)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate Chemical compound NCCCC(O)=O.O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CNXHSMPAOQXDRE-BLPRJPCASA-N 0.000 description 1
- HLOFWGGVFLUZMZ-UHFFFAOYSA-N 4-hydroxy-4-(6-methoxynaphthalen-2-yl)butan-2-one Chemical compound C1=C(C(O)CC(C)=O)C=CC2=CC(OC)=CC=C21 HLOFWGGVFLUZMZ-UHFFFAOYSA-N 0.000 description 1
- RMQJECWPWQIIPW-UHFFFAOYSA-N 4-hydroxycrotonic acid Chemical compound OCC=CC(O)=O RMQJECWPWQIIPW-UHFFFAOYSA-N 0.000 description 1
- MEANFMOQMXYMCT-OLZOCXBDSA-N 5,10-methenyltetrahydrofolic acid Chemical compound C([C@H]1CNC2=C([N+]1=C1)C(=O)N=C(N2)N)N1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C([O-])=O)C=C1 MEANFMOQMXYMCT-OLZOCXBDSA-N 0.000 description 1
- GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 description 1
- QUKRTJQSGPLQKQ-UHFFFAOYSA-N 5-methylsulfonyl-3h-1,3-benzoxazol-2-one Chemical compound CS(=O)(=O)C1=CC=C2OC(=O)NC2=C1 QUKRTJQSGPLQKQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 102100028704 Acetyl-CoA acetyltransferase, cytosolic Human genes 0.000 description 1
- 241000604450 Acidaminococcus fermentans Species 0.000 description 1
- 241001165345 Acinetobacter baylyi Species 0.000 description 1
- 241000948980 Actinobacillus succinogenes Species 0.000 description 1
- 108020000543 Adenylate kinase Proteins 0.000 description 1
- 102000002281 Adenylate kinase Human genes 0.000 description 1
- 241000567139 Aeropyrum pernix Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 1
- 101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000722954 Anaerobiospirillum succiniciproducens Species 0.000 description 1
- 241001136167 Anaerotignum propionicum Species 0.000 description 1
- 241000428313 Anaerotruncus colihominis Species 0.000 description 1
- 108010006591 Apoenzymes Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 102100032948 Aspartoacylase Human genes 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 101000695175 Bacillus subtilis (strain 168) Probable phosphate butyryltransferase Proteins 0.000 description 1
- 101100098786 Bacillus subtilis (strain 168) tapA gene Proteins 0.000 description 1
- 108010029692 Bisphosphoglycerate mutase Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- 101150054117 CAT1 gene Proteins 0.000 description 1
- IERHLVCPSMICTF-XVFCMESISA-N CMP group Chemical group P(=O)(O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C(=O)N=C(N)C=C1)O)O IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 101800004419 Cleaved form Proteins 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000423302 Clostridium acetobutylicum ATCC 824 Species 0.000 description 1
- 241000193454 Clostridium beijerinckii Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241001508458 Clostridium saccharoperbutylacetonicum Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 241000186520 Clostridium tetanomorphum Species 0.000 description 1
- 241000193452 Clostridium tyrobutyricum Species 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 229910020521 Co—Zn Inorganic materials 0.000 description 1
- 102100030497 Cytochrome c Human genes 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- 108010048689 D-lysine 5,6-aminomutase Proteins 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- 102000007528 DNA Polymerase III Human genes 0.000 description 1
- 108010071146 DNA Polymerase III Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 101100269671 Dictyostelium discoideum alrA gene Proteins 0.000 description 1
- 108010044229 Dihydroflavanol 4-reductase Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000190844 Erythrobacter Species 0.000 description 1
- 101100321116 Escherichia coli (strain K12) yqhD gene Proteins 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 241000702191 Escherichia virus P1 Species 0.000 description 1
- 241000193456 Eubacterium barkeri Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 1
- 108010080982 Formate-tetrahydrofolate ligase Proteins 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 241000192128 Gammaproteobacteria Species 0.000 description 1
- 241000388455 Gigasiphon Species 0.000 description 1
- 241000589232 Gluconobacter oxydans Species 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000204946 Halobacterium salinarum Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000837584 Homo sapiens Acetyl-CoA acetyltransferase, cytosolic Proteins 0.000 description 1
- 101000598552 Homo sapiens Acetyl-CoA acetyltransferase, mitochondrial Proteins 0.000 description 1
- 101000797251 Homo sapiens Aspartoacylase Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 101000927268 Hyas araneus Arasin 1 Proteins 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010081409 Iron-Sulfur Proteins Proteins 0.000 description 1
- 102000005298 Iron-Sulfur Proteins Human genes 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- LKDRXBCSQODPBY-NSHGFSBMSA-N L-fructose Chemical compound OCC1(O)OC[C@H](O)[C@H](O)[C@H]1O LKDRXBCSQODPBY-NSHGFSBMSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-JFNONXLTSA-N L-mannopyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 108010001469 L-rhamnose isomerase Proteins 0.000 description 1
- QZNPNKJXABGCRC-FUTKDDECSA-N L-rhamnulose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)C(=O)CO QZNPNKJXABGCRC-FUTKDDECSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WVZVXSGGSA-N L-xylulose Chemical compound OC[C@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-WVZVXSGGSA-N 0.000 description 1
- 241000235087 Lachancea kluyveri Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000222734 Leishmania mexicana Species 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 102100025357 Lipid-phosphate phosphatase Human genes 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102100026665 Malonate-CoA ligase ACSF3, mitochondrial Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000157876 Metallosphaera sedula Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010010685 Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 1
- 108010030837 Methylenetetrahydrofolate Reductase (NADPH2) Proteins 0.000 description 1
- 102000005954 Methylenetetrahydrofolate Reductase (NADPH2) Human genes 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 241000193459 Moorella thermoacetica Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000186366 Mycobacterium bovis Species 0.000 description 1
- 101100269700 Mycolicibacterium smegmatis alr gene Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000863422 Myxococcus xanthus Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- OQIBVCOJOZISOM-UHFFFAOYSA-N NCCCC(OOP(O)=O)=O Chemical compound NCCCC(OOP(O)=O)=O OQIBVCOJOZISOM-UHFFFAOYSA-N 0.000 description 1
- 241000167284 Natranaerobius Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- FXDNYOANAXWZHG-VKHMYHEASA-N O-phospho-L-homoserine Chemical compound OC(=O)[C@@H](N)CCOP(O)(O)=O FXDNYOANAXWZHG-VKHMYHEASA-N 0.000 description 1
- 101710164401 Omega-aminotransferase Proteins 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 241000228150 Penicillium chrysogenum Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 1
- 108090000472 Phosphoenolpyruvate carboxykinase (ATP) Proteins 0.000 description 1
- 102000011025 Phosphoglycerate Mutase Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 1
- 241000986839 Porphyromonas gingivalis W83 Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 102000055027 Protein Methyltransferases Human genes 0.000 description 1
- 108700040121 Protein Methyltransferases Proteins 0.000 description 1
- 241001528479 Pseudoflavonifractor capillosus Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 101000937808 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Beta-alanine-pyruvate aminotransferase Proteins 0.000 description 1
- 101000593541 Pseudomonas putida Omega-amino acid-pyruvate aminotransferase Proteins 0.000 description 1
- 241000205160 Pyrococcus Species 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 101100208039 Rattus norvegicus Trpv5 gene Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 238000005602 Reppe reaction Methods 0.000 description 1
- 241001148115 Rhizobium etli Species 0.000 description 1
- 241000589194 Rhizobium leguminosarum Species 0.000 description 1
- 241000191025 Rhodobacter Species 0.000 description 1
- 241000605947 Roseburia Species 0.000 description 1
- 241000516658 Roseiflexus castenholzii Species 0.000 description 1
- 101100101631 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) UGA2 gene Proteins 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 108010034546 Serratia marcescens nuclease Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 101100398785 Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) ldhD gene Proteins 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 108050003834 Succinate CoA transferases Proteins 0.000 description 1
- 241000205101 Sulfolobus Species 0.000 description 1
- 241000160715 Sulfolobus tokodaii Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241001147775 Thermoanaerobacter brockii Species 0.000 description 1
- 241000204666 Thermotoga maritima Species 0.000 description 1
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 241000589892 Treponema denticola Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000223105 Trypanosoma brucei Species 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 102000016540 Tyrosine aminotransferases Human genes 0.000 description 1
- 108050006053 Tyrosine aminotransferases Proteins 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- 241000588901 Zymomonas Species 0.000 description 1
- 101100386830 Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) ddh gene Proteins 0.000 description 1
- 241000029538 [Mannheimia] succiniciproducens Species 0.000 description 1
- GFCDJPPBUCXJSC-UHFFFAOYSA-N [O-2].[Zn+2].[Cu]=O Chemical compound [O-2].[Zn+2].[Cu]=O GFCDJPPBUCXJSC-UHFFFAOYSA-N 0.000 description 1
- QLWHXSONVMERFV-UHFFFAOYSA-N [Th].[Co].[Ni]=O Chemical compound [Th].[Co].[Ni]=O QLWHXSONVMERFV-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 101150081631 aldA gene Proteins 0.000 description 1
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- PYMYPHUHKUWMLA-WISUUJSJSA-N aldehydo-L-xylose Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WISUUJSJSA-N 0.000 description 1
- 229930195726 aldehydo-L-xylose Natural products 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 101150063145 atoA gene Proteins 0.000 description 1
- 101150008413 atoD gene Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- RTGHRDFWYQHVFW-UHFFFAOYSA-N beta-Ketoadipic acid Natural products OC(=O)CCC(=O)CC(O)=O RTGHRDFWYQHVFW-UHFFFAOYSA-N 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 229910002090 carbon oxide Inorganic materials 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229940022769 d- lactic acid Drugs 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000006477 desulfuration reaction Methods 0.000 description 1
- 230000023556 desulfurization Effects 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- RAYJUFCFJUVJBB-UHFFFAOYSA-N dihydrokaempferol Natural products OC1Oc2c(O)cc(O)cc2C(=O)C1c3ccc(O)cc3 RAYJUFCFJUVJBB-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- UKFXDFUAPNAMPJ-UHFFFAOYSA-N ethylmalonic acid Chemical compound CCC(C(O)=O)C(O)=O UKFXDFUAPNAMPJ-UHFFFAOYSA-N 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 238000011331 genomic analysis Methods 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 108010071598 homoserine kinase Proteins 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004434 industrial solvent Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 150000004723 keto acid derivatives Chemical class 0.000 description 1
- 235000020061 kirsch Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 101150026107 ldh1 gene Proteins 0.000 description 1
- 101150041530 ldha gene Proteins 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 108010089734 malonyl-CoA synthetase Proteins 0.000 description 1
- 101150079876 mcrB gene Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000010742 number 1 fuel oil Substances 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 108010025593 phenylalanine (histidine) aminotransferase Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- HPXUYGFXGORCIX-UHFFFAOYSA-N phosphono 4-aminobutaneperoxoate Chemical compound NCCCC(=O)OOP(O)(O)=O HPXUYGFXGORCIX-UHFFFAOYSA-N 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 150000003071 polychlorinated biphenyls Chemical class 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000007259 schaedler broth Substances 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- XCOBLONWWXQEBS-UHFFFAOYSA-N trimethylsilyl 2,2,2-trifluoro-n-trimethylsilylethanimidate Chemical compound C[Si](C)(C)OC(C(F)(F)F)=N[Si](C)(C)C XCOBLONWWXQEBS-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
- B01D3/001—Processes specially adapted for distillation or rectification of fermented solutions
- B01D3/002—Processes specially adapted for distillation or rectification of fermented solutions by continuous methods
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01157—3-Hydroxybutyryl-CoA dehydrogenase (1.1.1.157)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01055—3-Hydroxybutyryl-CoA dehydratase (4.2.1.55)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
本出願は、それぞれの内容全体が引用により本明細書中に組み込まれている、2008年9月10日に出願された米国仮出願第61/191,710号及び2008年9月17日に出願された、米国仮出願第61/192,511号の優先権を主張するものである。
本発明は、1,4-ブタンジオール(BDO)を生成するのに十分な量で発現されるBDO経路酵素をコードする少なくとも1つの外因性核酸を含むBDO経路を含む非天然微生物体を提供する。本発明は、さらに、当該微生物体を使用してBDOを生成する方法を提供する。
本発明は、4-ヒドロキシブタン酸(4-HB)、γ-ブチロラクトン及び1,4-ブタンジオール(BDO)の生合成生成機能を有する細胞及び生物体の設計及び生成に関する。本発明は、特に、BDO経路酵素をコードする1つ以上の核酸を導入することによってBDOを生成することが可能な微生物体の設計に関する。
2CO2 + 4H2 + nADP + nPi → CH3COOH + 2H2O + nATP
したがって、Wood-Ljungdahl経路を有する非天然微生物は、アセチル-CoA及び他の所望の生成物を生成するためにCO2とH2の混合物をも利用することができる。
(4-ヒドロキシブタン酸の生合成)
本実施例では、4-HB生成のための例示的な生化学合成経路について記載する。
(コハク酸及びアルファ-ケトグルタル酸からの1,4-ブタンジオールの生合成)
本実施例では、微生物体からの4-HB及びBDOの構築及び生合成生成を例示する。4-HB及びBDOのための経路は、本明細書に開示されている。
lacZalpha-RI
本明細書に記載のすべての研究における親菌株は、大腸菌K-12菌株MG1655である。adhE、gabD及びaldAにおける無マーカー欠失株を、redET法(Datsenko, K. A.及びB. L. Wanner、Proc Natl Acad Sci U SA 97:6640-6645(2000))を使用して、第三者によるサービス契約に基づいて構築した。次の菌株を、バクテリオファージP1媒介形質導入(Miller, J. Experiments in Molecular Genetics、Cold Spring Harbor Laboratories、New York(1973))を介して構築した。菌株C600Z1(laciq、PN25-tetR、SpR、lacY1、leuB6、mcrB+、supE44、thi-1、thr-1、tonA21)をExpressysから入手し、P1形質導入のためのlacIq対立遺伝子源として使用した。バクテリオファージP1virを、lacIqに結合したスペクチノマイシン抵抗遺伝子を有するC600Z1大腸菌株上で成長させた。C600Z1上で成長したP1溶菌液を使用して、スペクチノマイシン抵抗についての選択によりMG1655を感染させた。次いで、スペクチノマイシン抵抗コロニーを、PAllacO-1プロモーターに結合した遺伝子の発現を抑制する形質導入体の能力を測定することによって、結合したlacIqについて選別した。得られた菌株をMG1655 lacIqと命名した。同様の手順を使用して、lacIqを欠失菌株に導入した。
コハク酸から4-HB産生株を構築するために、以下に記載するように、コハク酸から4-HB及び4-HB-CoAまでの工程(図1の1、6、7及び9)をコードする遺伝子をpZA33及びpZE13上に集めた。様々な遺伝子の組合せ、並びに対照として不完全な経路を保持する構造体を評価した(表7及び8)。次いで、イソプロピルβ-D-1-チオガラクトピラノシド(IPTG)を添加することによって、誘発性発現を可能にする、lacIQを含む宿主菌株にプラスミドを変換した。野生型、及び原生コハク酸セミアルデヒドデヒドロゲナーゼをコードする遺伝子が欠失した宿主の両方(図1の工程2)を試験した。
活性アッセイのための粗抽出物を得るために、細胞を、10分間にわたる4500rpmの遠心(Beckman-Coulter、Allegera X-15R)によって収穫した。ペレットを、ベンゾナーゼ及びライソザイムを含む0.3mLのBugBuster(Novagen)に再懸濁させ、静かに振盪しながら室温で15分間溶解させた。無細胞溶菌液を、4℃にて30分間にわたって14000rpmで遠心させること(Eppendorf遠心器5402)によって得た。サンプルにおける細胞タンパク質を、Bradfordら、Anal. Biochem. 72:248-254(1976)の方法を使用して測定し、特定の酵素アッセイを以下に記載するように実施した。活性を、活性の単位が、1μmの基質を室温にて1分間で変換するのに必要とされる酵素の量で定義されるタンパク質1mg当たりの単位で報告する。概して、報告された値は、少なくとも3回のアッセイの平均値である。
補酵素A(CoA)転移を含む酵素反応を監視するためにHPLCに基づくアッセイを開発した。開発された方法は、インビトロ反応混合物に存在するCoA、アセチルCoA(AcCoA)、ブチリルCoA(BuCoA)及び4-ヒドロキシ酪酸CoA(4-HBCoA)の定量測定によって特徴づけられる酵素活性を可能にした。低μMへの感度の低下、並びに対象となるすべてのCoA誘導体の優れた分解能が達成された。
上記実験は、中心代謝中間体(コハク酸)から4-HBへの機能的経路を実証しているが、工業的方法では、グルコース又はスクロースなどの低コスト炭水化物からの化学物質の生成が必要になる。したがって、次の実験群は、グルコース上での成長時に細胞によって生成された内因性コハク酸が、4-HB経路を供給し得るかどうかを判断することを目的とした。20g/Lのグルコース、緩衝能力を向上させるための100mMの3-(N-モルホリノ)プロパンスルホン酸(MOPS)、10μg/mLのチアミン及び適切な抗生物質が補給されたM9最小培地(6.78g/LのNa2HPO4、3.0g/LのKH2PO4、0.5g/LのNaCl、1.0g/LのNH4Cl、1mMのMgSO4、0.1mMのCaCl2)にて嫌気性条件で細胞を成長させた。OD600が約0.2に達すると0.25mMのIPTGを添加し、誘発後24時間毎に4-HB分析のためにサンプルを採取した。いずれの場合も、最良の菌株において約1mMの最大値で、4-HBが24時間後に安定水準に達した(図3a)のに対して、コハク酸濃度は、上昇し続けた(図3b)。これは、経路へのコハク酸の供給が恐らくは限定的でないこと、及び障害が酵素そのものの活性又はNADH利用能にあり得ることを示している。0.035及び0.036は、明らかに、それぞれCoA依存性コハク酸セミアルデヒドデヒドロゲナーゼ及び4-HBデヒドロゲナーゼの最良の遺伝子候補である。既知(gabD)又は推定上(aldA)の原生コハク酸セミアルデヒドデヒドロゲナーゼをコードする遺伝子の一方又は双方を除外しても性能に対する影響がほとんどなかった。最後に、細胞は、対照より4-HB生成菌株においてはるかに低いODまで成長したことに留意されたい(図3c)。
4-HBからのBDOの生成には、デヒドロゲナーゼによって触媒される2つの還元工程が必要であった。アルコール及びアルデヒドデヒドロゲナーゼ(それぞれADH及びALD)は、ともに分子上のカルボン酸基をアルコール基に還元できる、又は逆にアルコールのカルボン酸への酸化を実施できるNAD+/H及び/又はNADP+/H依存性酵素である。この生体内変換は、野生型クロストリジウム・アセトブチリクムにおいて実証されたが(Jewellら、Current Microbiology、13:215-19(1986))、関与する酵素も関与する遺伝子も特定されなかった。加えて、4-HB-CoAに対する活性化が最初に必要であるかどうか(図1の工程9)、又はアルデヒドデヒドロゲナーゼ(工程12)が4-HBに対して直接作用できるかどうかが把握されていない。本発明者らは、4-HB及び経路中間体に対する非ヒドロキシル化類似体による既知の活性に基づいて、又はこれらの特徴づけられた遺伝子に対する類似性により、C. アセトブチリクム及び関連生物体からの候補酵素の一覧を作成した(表6)。これらの候補の一部は多官能価デヒドロゲナーゼであるため、それらは、潜在的に酸(又はCoA誘導体)のアルデヒドへの、且つアルデヒドのアルコールへのNAD(P)H依存性還元の両方を触媒する。大腸菌におけるこれらの遺伝子を用いた研究を開始する前に、C.アセトブチリクムATCC824を使用して、上記の結果を最初に検証した。30℃にて10%CO2、10%H2及び80%N2の嫌気性雰囲気中で、10mMの4-HBが補給されたSchaedler肉汁(Accumedia、ミシガン州Lansing)で細胞を成長させた。定期的な培養サンプルを採取し、遠心し、以下に記載されるように肉汁をGC-MSによってBDOについて分析した。0.1mM、0.9mM及び1.5mMのBDO濃度をそれぞれ1日後、2日後及び7日後に検出した。4-HBを添加せずに成長した培養物にはBDOが検出されなかった。生成されたBDOがグルコースから誘導されることを実証するために、最良のBDO生成菌株MG1655lacIQpZE13-0004-0035-0002pZA33-0034-0036を、4g/Lの均一標識13C-グルコースが補給されたM9最小培地で成長させた。細胞を1mMのIPTGで0.67のODにおいて誘発し、サンプルを24時間後に採取した。培養上澄みの分析を質量分析によって実施した。
経路確認の最終工程は、大腸菌における経路の4-HB及びBDO部分の両方を発現し、グルコース最小培地におけるBDOの生成を実証することである。すべての必要な遺伝子が2つのプラスミドに適合するように新たなプラスミドを構築した。概して、cat1、adhE及びsucD遺伝子をpZE13から発現させ、cat2及び4-HBdをpZA33から発現させた。遺伝子源及び遺伝子順序の様々な組合せをMG1655lacIQバックグラウンドで試験した。20g/Lのグルコース、緩衝能力を向上させるための100mMの3-(N-モルホリノ)プロパンスルホン酸(MOPS)、10μg/mLのチアミン及び適切な抗生物質が補給されたM9最小培地(6.78g/LのNa2HPO4、3.0g/LのKH2PO4、0.5g/LのNaCl、1.0g/LのNH4Cl、1mMのMgSO4、0.1mMのCaCl2)にて嫌気性条件で細胞を成長させた。摂取の約15時間後に0.25mMのIPTGを添加し、BDO、4-HBについて培養上澄みサンプルを採取し、誘発の24及び48時間後にコハク酸分析を行った。BDOの生成量は、遺伝子順序への依存性を示すように思われた(表12)。pZA33上に最初にcat2を発現させた後に4-HBdを発現させ、pZE13上にcat1を発現させた後にP.ギンギバリスsucDを発現させると、0.5mMを超える最大のBDO生成量が得られた。C.アセトブチリクムashE2をpZE13上の最後の位置に添加すると、わずかな向上がもたらされた。4-HB及びコハク酸もより高い濃度で生成された。
発酵及び細胞培養サンプルにおけるBDO、4-HB及びコハク酸をシリル化によって誘導体化し、文献報告から採用された方法(Simonovら、J. Anal Chem. 59:965-971(2004))を使用してGCMSにより定量分析した。開発された方法は、1μMまでの良好な感度、少なくとも25mMまでの直線性、並びに優れた選択性及び再現性を示した。
また、様々な代替的経路をBDO生成について試験した。これは、コハク酸をスクシニル-CoA(表13、第2〜3列)に変換する原生大腸菌SucCD酵素の使用、α-ケトグルタル酸経路におけるα-ケトグルタル酸デカルボキシラーゼの使用(表13、第4列)、及び4HBのCoA誘導体を生成するための代替的手段としてのPTB/BKの使用を含む。これらの変異体を包含する、表13に示される遺伝子を発現するプラスミドを含む菌株を構築した。それらの結果は、すべての場合において、4-HB及びBDOの生成が生じたことを示している(表13)。
(4-ヒドロキシブタン酸、γ-ブチロラクトン及び1,4-ブタンジオールの生合成)
本実施例では、発酵及び他のバイオプロセスを使用する4-ヒドロキシブタン酸、γ-ブチロラクトン及び1,4-ブタンジオールの生合成生成について記載する。
5g/Lのリン酸カリウム、2.5g/Lの塩化アンモニウム、0.5g/Lの硫酸マグネシウム及び30g/Lのコーンスティープリッカーを含む5Lの肉汁並びに20g/Lの初期グルコース濃度を使用して、N2/CO2混合物が散布された10Lバイオリアクターにて生成生物体を成長させる。細胞が成長し、グルコースを利用すると、さらなる70%のグルコースを、グルコース消費量をほぼ均衡化させる速度でバイオリアクターに供給する。バイオリアクターの温度を摂氏30度に維持する。4-HBが20〜200g/Lの濃度に達し、細胞密度が5から10g/Lになるまで成長を約24時間続ける。pHは制御されず、典型的には実験の終了時までにpH3〜6まで低下することになる。培養時間が終了すると、発酵槽内容物を細胞分離ユニット(例えば遠心器)に通して、細胞及び細胞細片を除去し、発酵肉汁を生成物分離ユニットに移す。4-HB/GBLの有機溶液を得るために、不水溶性有機溶媒(例えばトルエン)を使用する液液抽出などの、有機生成物を希釈水溶液から分離するために当該技術分野で採用される標準分離手順によって、4-HB及び/又はGBLの単離を行うことになる。次いで、得られた溶液に標準的な蒸留法を施して、有機溶媒を除去及びリサイクルするとともに、精製液として単離されるGBL(沸点204〜205℃)を得る。
初期グルコース濃度を30〜50g/Lにすることを除いては、上記の装置及び培地組成を使用して生成生物体を最初にバッチ方式で成長させる。グルコースを使い果たすと、同じ組成の供給培地を0.5L/時及び1L/時の速度で連続的に供給し、液体を同じ速度で回収する。バイオリアクターにおける4-HB濃度を30〜40g/Lの一定値に維持し、細胞密度を3〜5g/Lの一定値に維持する。温度を摂氏30度に維持し、必要に応じて濃NaOH及びHClを使用してpHを4.5に維持する。バイオリアクターを1ヶ月間にわたって連続的に動作させ、4-HBの濃度の一貫性を確認するためにサンプルを毎日採取する。連続方式では、新たな供給培地が供給される毎に発酵槽内容物を除去する。次いで、細胞、培地並びに生成物4-HB及び/又はGBLを含む排出流に、細胞及び細胞細片を除去する、又は除去しない連続生成物分離手順を施し、4-HB/GBLの有機溶液を得るために、不水溶性有機溶媒(例えばトルエン)を使用する連続液液抽出などの、有機生成物を希釈水溶液から分離するために当該技術分野で採用される標準分離手順によって行うことになる。続いて、得られた溶液に標準連続蒸留法を施して、有機溶媒を除去及びリサイクルするとともに、精製液として単離されるGBL(沸点204〜205℃)を得る。
BLを上記のように単離及び精製すると、それに当該技術分野で周知のもの(引用参考文献)などの還元プロトコルを施して、1,4-ブタンジオール又はテトラヒドロフラン(THF)或いはそれらの混合物を生成する。水素圧下でGBLと組み合わされた異種又は同種水素化触媒は、生成物1,4-ブタンジオール又はテトラヒドロフラン(THF)又はそれらの混合物を与えることが周知である。GBL単離及び精製の前に、上記のように発酵肉汁から分離された4-HB/GBL生成物混合物にこれらの同じ還元プロトコルを直接施して、生成物1,4-ブタンジオール又はテトラヒドロフラン又はそれらの混合物を得ることができる。次いで、得られた生成物の1,4-ブタンジオール及びTHFを、当該技術分野で周知の手順によって単離及び精製する。
5g/Lのリン酸カリウム、2.5g/Lの塩化アンモニウム、0.5g/Lの硫酸マグネシウム及び30g/Lのコーンスティープリッカーを含む5Lの肉汁並びに20g/Lの初期グルコース濃度を使用して、N2/CO2混合物が散布された10Lバイオリアクターにて細胞を成長させる。細胞が成長し、グルコースを利用すると、さらなる70%のグルコースを、グルコース消費量をほぼ均衡化させる速度でバイオリアクターに供給する。バイオリアクターの温度を摂氏30度に維持する。4-HBが20〜200g/Lの濃度に達し、細胞密度が全般的に5から10g/Lになるまで成長を約24時間続ける。pHは制御されず、典型的には実験の終了時までにpH3〜6まで低下することになる。培養時間が終了すると、発酵槽内容物を細胞分離ユニット(例えば遠心器)に通して、細胞及び細胞細片を除去し、発酵肉汁を還元ユニット(例えば水素化容器)に移し、そこで4-HB/GBL混合物を1,4-ブタンジオール又はTHF又はそれらの混合物に直接還元する。還元手順の完了後に、反応器内容物を生成物分離ユニットに移す。1,4-ブタンジオール及び/又はTHFの有機溶液を得るために、不水溶性有機溶媒(例えばトルエン)を使用する液液抽出などの、有機生成物を希釈水溶液から分離するために当該技術分野で採用される標準分離手順によって、1,4-ブタンジオール及び/又はTHFの単離を行うことになる。次いで、得られた溶液に標準的な蒸留法を施して、有機溶媒を除去及びリサイクルするとともに、精製液として単離される1,4-ブタンジオール及び/又はTHFを得る。
初期グルコース濃度を30〜50g/Lにすることを除いては、上記の装置及び培地組成を使用して細胞を最初にバッチ方式で成長させる。グルコースを使い果たすと、同じ組成の供給培地を0.5L/時及び1L/時の速度で連続的に供給し、液体を同じ速度で回収する。バイオリアクターにおける4-HB濃度を30〜40g/Lの一定値に維持し、細胞密度を3〜5g/Lの一定値に維持する。温度を摂氏30度に維持し、必要に応じて濃NaOH及びHClを使用してpHを4.5に維持する。バイオリアクターを1ヶ月間にわたって連続的に動作させ、4-HBの濃度の一貫性を確認するためにサンプルを毎日採取する。連続方式では、新たな供給培地が供給される毎に発酵槽内容物を除去する。次いで、細胞、培地並びに生成物4-HB及び/又はGBLを含む排出流を細胞分離ユニット(例えば遠心器)に通して、細胞及び細胞細片を除去し、発酵肉汁を連続還元ユニット(例えば水素化容器)に移し、そこで4-HB/GBL混合物を1,4-ブタンジオール又はTHF又はそれらの混合物に直接還元する。還元手順の完了後に、反応器内容物を連続生成物分離ユニットに移す。1,4-ブタンジオール及び/又はTHFの有機溶液を得るために、不水溶性有機溶媒(例えばトルエン)を使用する液液抽出などの、有機生成物を希釈水溶液から分離するために当該技術分野で採用される標準連続分離手順によって、1,4-ブタンジオール及び/又はTHFの単離を行うことになる。次いで、得られた溶液に標準的な蒸留法を施して、有機溶媒を除去及びリサイクルするとともに、精製液として単離される1,4-ブタンジオール及び/又はTHFを得る。
5g/Lのリン酸カリウム、2.5g/Lの塩化アンモニウム、0.5g/Lの硫酸マグネシウム及び30g/Lのコーンスティープリッカーを含む5Lの肉汁並びに20g/Lの初期グルコース濃度を使用して、N2/CO2混合物が散布された10Lバイオリアクターにて生成生物体を成長させる。細胞が成長し、グルコースを利用すると、さらなる70%のグルコースを、グルコース消費量をほぼ均衡化させる速度でバイオリアクターに供給する。バイオリアクターの温度を摂氏30度に維持する。BDOが20〜200g/Lの濃度に達し、細胞密度が全般的に5から10g/Lになるまで成長を約24時間続ける。培養時間が終了すると、発酵槽内容物を細胞分離ユニット(例えば遠心器)に通して、細胞及び細胞細片を除去し、発酵肉汁を生成物分離ユニットに移す。BDOの有機溶液を得るために、不水溶性有機溶媒(例えばトルエン)を使用する液液抽出などの、有機生成物を希釈水溶液から分離するために当該技術分野で採用される標準分離手順によって、BDOの単離を行うことになる。次いで、得られた溶液に標準的な蒸留法を施して、有機溶媒を除去及びリサイクルするとともに、精製液として単離されるBDO(沸点228〜229℃)を得る。
初期グルコース濃度を30〜50g/Lにすることを除いては、上記の装置及び培地組成を使用して生成生物体を最初にバッチ方式で成長させる。グルコースを使い果たすと、同じ組成の供給培地を0.5L/時及び1L/時の速度で連続的に供給し、液体を同じ速度で回収する。バイオリアクターにおけるBDO濃度を30〜40g/Lの一定値に維持し、細胞密度を3〜5g/Lの一定値に維持する。温度を摂氏30度に維持し、必要に応じて濃NaOH及びHClを使用してpHを4.5に維持する。バイオリアクターを1ヶ月間にわたって連続的に動作させ、BDOの濃度の一貫性を確認するためにサンプルを毎日採取する。連続方式では、新たな供給培地が供給される毎に発酵槽内容物を絶えず除去する。次いで、細胞、培地並びに生成物BDOを含む排出流に、細胞及び細胞細片を除去する、又は除去しない連続生成物分離手順を施し、BDOの有機溶液を得るために、不水溶性有機溶媒(例えばトルエン)を使用する連続液液抽出などの、有機生成物を希釈水溶液から分離するために当該技術分野で採用される標準分離手順によって行うことになる。続いて、得られた溶液に標準連続蒸留法を施して、有機溶媒を除去及びリサイクルするとともに、精製液として単離されるBDO(沸点228〜229℃)を得る(融点20℃)。
(例示的なBDO経路)
本実施例では、1,4-ブタンジオール(BDO)合成経路についての例示的な酵素及び対応する遺伝子を記載する。
アルデヒドからアルコール.アルデヒドからアルコールの変換を触媒する酵素、即ちアルコールデヒドロゲナーゼ又は同等にアルデヒドレダクターゼをコードする例示的な遺伝子は、C2〜C14の中鎖アルコールデヒドロゲナーゼをコードするalrA(Taniら、Appl. Environ. Microbiol. 66:5231-5235(2000))、サッカロマイセス・セレビシアエのADH2(Atsumiら、Nature 451:86-89(2008))、C(3)より長い分子を選択する大腸菌のyqhD(Sulzenbacherら、Journal of Molecular Biology 342:489-502(2004))ブチリアルデヒドをブタノールに変換するC.アセトブチリクムのbdhI及びbdhII(Walterら、Journal of Bacteriology 174:7149-7158(1992))を含む。これらの例示的な遺伝子生成物の各々についてのタンパク質配列を、入手可能であれば、以下のGenBankアクセッション番号を使用して見いだすことができる。
アシル-CoAをアルコールに変換する例示的な2工程オキシドレダクターゼは、基質を変換するもの、例えば、アセチル-CoAをエタノールに変換するもの(例えば、大腸菌のadhE(Kesskerら、FEBS. Lett. 281:59-63(1991))及びブチリル-CoAをブタノールに変換するもの(例えば、C.アセトブチリクムのadhE2(Fontaineら、J. Bacteriol. 184:821-830(2002))を含む。アセチル-CoAをエタノールに還元することに加えて、ロイコノストク・メセンテロイデスにおけるadhEによってコードされる酵素は、分枝鎖化合物イソブチルアルデヒドをイソブチリル-CoAに酸化することが証明された(Kazahayaら、J. Gen.Appl.Microbiol. 18;43-55(1972); Kooら、Biotechnol Lett. 27:505-510(2005))。
いくつかのアシル-CoAデヒドロゲナーゼは、アシル-CoAを、その対応するアルデヒドに還元することが可能である。当該酵素をコードする例示的な遺伝子は、脂肪アシル-CoAレダクターゼをコードするアシネトバクテル・カルコアセチクス(Acinetobacter calcoaceticus)acr1(Reiser及びSomerville、J. Bacteriology 179:2969-2975(1997))、アシネトバクテル属M-1脂肪アシル-CoAレダクターゼ(Ishigeら、Appl.Environ.Microbiol. 68:1192-1195(2002))、並びにクロストリジウム・クルイベリにおけるsucD遺伝子によってコードされるCoA及びNADP依存性コハク酸セミアルデヒドデヒドロゲナーゼ(Sohling及びGottschalk J Bacteriol 178:871-80(1996);Sohling及びGottschalk J Bacteriol. 178:871-880 (1996))を含む。P.ギンギバリスのSucDは、別のコハク酸セミアルデヒドデヒドロゲナーゼである(Takahashiら、J.Bacteriol. 182:4704-4710 (2000))。bphGによってコード化される、シュードモナス属におけるアセトアルデヒドデヒドロゲナーゼをアシル化する酵素は、アセトアルデヒド、プロピオンアルデヒド、ブチルアルデヒド、イソブチルアルデヒド及びホルムアルデヒドを酸化及びアシル化することが証明されたため、さらに別の酵素である(Powlowskiら、J Bacteriol. 175:377-385(1993))。
この系統の酵素は、1)分枝鎖2-ケト酸デヒドロゲナーゼ、2)アルファ-ケトグルタル酸デヒドロゲナーゼ及び3)ピルビン酸デヒドロゲナーゼ多酵素複合体(PDHC)を含む。これらの酵素は、2-ケト酸の酸化性脱カルボキシル化をもたらす一連の部分反応を触媒する多酵素複合体である。2-ケト酸デヒドロゲナーゼ複合体のそれぞれは、中間的代謝における主要位置を占め、酵素活性は、典型的には厳密に制御される(Friesら、Biochemistry 42:6996-7002(2003))。それらの酵素は、アルファ-ケト酸デカルボキシラーゼ(E1)、ジヒドロリポアミドアシルトランスフェラーゼ(E2)及びジヒドロリポアミドデヒドロゲナーゼ(E3)の3つの触媒成分の多数の複製物で構成された複雑であるが、共通の構造体を共有する。E3成分は、生物体におけるすべての2-ケト酸デヒドロゲナーゼ複合体の間で共有され、E1及びE2成分は、異なる遺伝子によってコードされる。酵素成分は、複合体に多くの複製物で存在し、基質チャネリングを介して反応の指向性配列を触媒するために多数の共同因子を利用する。これらのデヒドロゲナーゼ複合体の全体的なサイズは非常に大きく、分子質量は、4から1000万Daである(即ち、リボソームより大きい)。
このクラスにおける例示的な酵素は、グリセルアルデヒド-3-リン酸をD-グリセリン酸1,3-ビスリン酸に変換するグリセルアルデヒド3-リン酸デヒドロゲナーゼ(例えば、大腸菌gapA(Branlant及びBranlant Eur. J. Biochem. 150:61-66(1985))、L-アスパラギン酸-4-セミアルデヒドをL-4-アスパルチル-リン酸に変換するアスパラギン酸-セミアルデヒドデヒドロゲナーゼ(例えば、大腸菌asd(Biellmannら、Eur. J. Biochem. 104:53-58(1980))、N-アセチル-L-グルタミン酸-5-セミアルデヒドをN-アセチル-L-グルタミル-5-リン酸に変換するN-アセチル-ガンマ-グルタミル-リン酸レダクターゼ(例えば、大腸菌argC(Parsotら、Gene 68:275-283(1988))、及びL-グルタミン酸-5-セミアルデヒドをL-グルタミル-5-リン酸に変換するグルタミン酸-5-セミアルデヒドデヒドロゲナーゼ(例えば、大腸菌proA(Smithら、J. Bacteriol. 157:545-551(1084))を含む。
例示的なエノイル-CoAレダクターゼは、クロトニル-CoAのブチリル-CoAへの還元を自然に触媒するC.アセトブチリクムのbcdの遺伝子生成物である(Atsumiら、Metab Eng(2007);Boyntonら、Journal of Bacteriology 178:3015-3024(1996))。電子転移フラボタンパク質をコードするC.アセトブチリクムetfAB遺伝子の発現と並行してbcdを発現させることによって酵素の活性を高めることができる。エノイル-CoAレダクターゼ工程のさらなる候補はE.グラシリス(gracilis)のミトコンドリアエノイル-CoAレダクターゼである(Hoffmeisterら、Journal of Biological Chemistry 280:4329-4338(2005))。そのミトコンドリア標的リーダー配列の除去に続いてこの配列から誘導された構造体を大腸菌に複製することで活性酵素を得た(Hoffmeisterら、前出、(2005))。このアプローチは、真核生物遺伝子、特に、原核生物体において、特定の細胞内区画に遺伝子生成物を導くことができるリーダー配列を有する遺伝子を発現させる技術分野の当業者に周知である。原核生物トレポネマ・デンチコラ(Treponema denticola)のこの遺伝子の近相同体TDE0597は、大腸菌において複製及び発現された第3のエノイル-CoAレダクターゼを表す(Tucci及びMartin FEBS Letters 581:1561-1566(2007))。
アミノ酸に作用するたいていのオキシドレダクターゼは、NAD+又はNADP+を受容体とするアルファ-アミノ酸の酸化性脱アミノ化を触媒する。アミノ酸に作用する例示的なオキシドレダクターゼは、gdhAによってコードされるグルタミン酸デヒドロゲナーゼ(脱アミノ化)、ldhによってコードされるロイシンデヒドロゲナーゼ(脱アミノ化)、及びnadXによってコード化されるアスパラギン酸デヒドロゲナーゼ(脱アミノ化)を含む。エシェリキア・コリのgdhA遺伝子生成物(Korberら、J. Mol. Biol. 234:1270-1273(1993);McPherson及びWootton Nucleic. Acids Res. 11:5257-5266(1983))、テルモトガ・マリチマのgdh(Kortら、Extremophiles 1:52-60(1997);Lebbinkら、J. Mol. Biol. 280:287-296(1998));Lebbinkら、J. Mol. Biol. 289:357-369(1999))、及びハロバクテリウム・サリナルムのgdhAl(Ingoldsbyら、Gene 349:237-244(2005))は、グルタミン酸と2-オキソグルタル酸及びアンモニアとの可逆的相互変換を触媒し、それぞれNADP(H)、NAD(H)又はその両方に有利に働く。バシルス・セレウスのldh遺伝子は、ロイシン、イソロイシン、バリン及び2-アミノブタン酸を含む広範な基質を有するLeuDHタンパク質をコードする(Ansorge及びKuIa Biotechnol Bioeng. 68:557-562(2000);Stoyanら、J.Biotechnol 54:77-80(1997))。アスパラギン酸デヒドロゲナーゼに対してコードするテルモトガ・マリチメ(Thermotoga maritime)のnadX遺伝子は、NADの生合成に関与する(Yangら、J.Biol.Chem. 278:8804-8808 (2003))。
例示的なリン酸転移アシルトランスフェラーゼは、ptaによってコードされるホスホトランスアセチラーゼ及びptbによってコードされるホスホトランスブチリラーゼを含む。大腸菌のpta遺伝子は、アセチル-CoAをアセチル-リン酸に、又はその逆に変換することができる酵素をコードする(Suzuki, T. Biochim. Biophys. Acta 191:559-569(1969))。この酵素は、そのプロセスでプロピオン酸を形成するアセチル-CoAの代わりにプロピオニル-CoAを利用することもできる(Hesslingerら、Mol.Microbiol 27:477-492(1998))。同様に、C.アセトブチリクムのptb遺伝子は、ブチリル-CoAをブチリル-リン酸に変換することができる酵素をコードする(Walterら、Gene 134(1):p. 107-11 (1993);Huangら、J Mol Microbiol Biotechnol 2(1):p.33-38(2000))。さらなるptb遺伝子を酪酸生成細菌L2-50(Louisら、J.Bacteriol.186:2099-2106(2004))及びバシルス・メガテリウム(Vazquezら、Curr.Microbiol 42:345-349(2001))に見いだすことができる。
例示的なキナーゼは、ackAによってコードされる大腸菌酢酸キナーゼ(Skarstedt及びSilverstein J. Biol. Chem. 251:6775-6783(1976))、buk1及びbuk2によってコードされるC.アセトブチリクム酪酸キナーゼ(Walterら、Gene 134(1):107-111(1993)(Huangら、J Mol Microbiol Biotechnol 2(l):33-38(2000)]、及びproβによってコードされる大腸菌ガンマ-グルタミルキナーゼ(Smithら、J.Bacteriol. 157:545-551(1984))を含む。これらの酵素は、それぞれ酢酸、酪酸及びグルタミン酸をリン酸化する。大腸菌のackA遺伝子生成物は、プロピオン酸をもリン酸化する(Hesslingerら、Mol. Microbiol 27:477-492(1998))。
CoA-トランスフェラーゼ系統において、酢酸-CoAトランスフェラーゼ(EC2.8.3.8)としても知られる大腸菌酵素アシル-CoA: 酢酸-CoAトランスフェラーゼは、イソ酪酸(Matthies及びSchink Appl Environ Microbiol 58:1435-1439(1992))、吉草酸(Vanderwinkelら、Biochem. Biophys. Res Commun. 33:902-908(1968)及びブタン酸(Vanderwinkel、前出(1968))を含む様々な分枝状及び直鎖状アシル-CoA基質からCoA部分を酢酸に転移することが証明された。この酵素は、大腸菌属K12におけるatoA(アルファサブユニット)及びatoD(ベータサブユニット)(Korolevら、Acta Crystallogr.D Biol Crystallogr. 58:2116-2121(2002); Vanderwinkel、前出(1968))、並びにコリネバクテリウム・グルタミクムにおけるactA及びcg0592(Duncanら、Appl Environ Microbiol 68:5186-5190(2002))によってコードされる。配列相同性によって見いだされるさらなる遺伝子は、エシェリキア・コリUT189のatoD及びatoAを含む。
CoAヒドロラーゼ系統において、酵素3-ヒドロキシイソブチリル-CoAヒドロラーゼは、3-HIBCoAに対して特異的であり、バリン分解中に所望の変換を効率的に触媒することが示された(Shimomuraら、J Biol Chem 269:14248-14253(1994))。この酵素をコードする遺伝子は、ラッタス・ノルベギクス(Shimomuraら、前出(1994);Shimomuraら、Methods Enzymol. 324:229-240(2000))及びホモサピエンス(Shimomuraら、前出、2000)のhibchを含む。配列相同性による候補遺伝子は、サッカロマイセス・セレビシアエのhibch及びバシルス・セレウスのBC_2292を含む。
189(19):7112-7126(2007))の遺伝子生成物を含む。
例示的なカルボキシ-リアーゼは、2-アセト乳酸をアセトインに変換するクエン酸異化及び分枝鎖アミノ酸生合成に関与するアセト乳酸デカルボキシラーゼである。ラクトコッカス・ラクチスにおいて、酵素は、遺伝子aldBによってコードされる6つのサブユニットで構成され、バリン、ロイシン及びイソロイシンによって活性化される(Goupilら、Appl.Environ.Microbiol. 62:2636-2640 (1996);Goupil-Feuilleratら、J.Bacteriol. 182:5399-5408(2000))。この酵素は、大腸菌において過剰発現され、特徴づけられた(Phalipら、FEBS Lett. 351:95-99(1994))。他の生物体において、該酵素は、ストレプトコッカス・テルモフィルスのaldC(Monnetら、Lett.Appl.Microbiol. 36:399-405(2003))、バシルス・ブレビスのaldB(Diderichsenら、J.Bacteriol. 172:4315-4321(1990);Najmudinら、Acta Crystallogr.D.Biol.Crystallogr. 59:1073-1075(2003))及びエンテロバクテル・アエロゲネスのbudA(Diderichsenら、J.Bacteriol. 172:4315-4321(1990))によってコードされる二量体である。バシルス・ブレビスの酵素は、バシルス・スブチリスにおいて複製及び過剰発現され、結晶学的に特徴づけられた(Najmudinら、Acta Crystallogr.D.Biol.Crystallogr. 59:1073-1075(2003))。また、ロイコノストク・ラクチスの酵素は、精製され、特徴づけられたが、遺伝子は単離されていない(O'Sullivanら、FEMS Microbiol.Lett. 194:245-249(2001))。
ケト酸デカルボキシラーゼとも呼ばれるピルビン酸デカルボキシラーゼ(PDC、EC4.1.1.1)は、ピルビン酸のアセトアルデヒドへの脱カルボキシル化を触媒する、アルコール発酵における主要酵素である。この酵素は、2-ケト酪酸、2-ケト吉草酸、3-ヒドロキシピルビン酸及び2-フェニルピルビン酸を含む、脂肪族2-ケト酸に対する広い基質範囲を有する(Bergら、Science 318:1782-1786(2007))。pdcによってコードされるジモモナス・モビルスのPDCは、異なる基質に対する親和性を変化させた指向的操作研究の対象になってきた(Siegertら、Protein Eng Des Sel 18:345-357 (2005))。サッカロミセス・セレビシアエのPDCも広範に研究され、変化した活性に対して操作され、大腸菌において機能的に発現された((Killenberg-Jabsら、Eur.J.Biochem. 268:1698-1704(2001);Li及びJordan Biochemistry 38:10004-10012(1999); ter Schureら、Appl.Environ.Microbiol. 64:1303-1307(1998))。この酵素の結晶構造が入手可能である(Killenberg-Jabs Eur.J.Biochem. 268:1698-1704(2001))。他の十分に特徴づけられたPDC候補は、アセトバクテル・パステウリアンス(Chandraら、Arch.Microbiol. 176:443-451(2001))及びクルイベロマイセス・ラクチス(Kriegerら、Eur.J.Biochem. 269:3256-3263(2002))の酵素を含む。
ユーバクテリウム・バルケリの2-(ヒドロキシメチル)グルタル酸デヒドラターゼは、例示的なヒドロ-リアーゼである。この酵素は、ニコチン酸異化の観点で研究され、hmdによってコードされる(Alhapelら、Proc Natl Acad Sci U S A 103:12341-12346(2006))。高度な配列相同性を有する類似の酵素が、バクテロイデス・カピロサス、アナエロツルンカス・コリホミニス及びナトラナエロビウス・テルモフィルスに見いだされる。
アスパラギン酸のフマル酸への脱アミノ化を触媒するアスパルターゼ(EC 4.3.1.1)は、微生物において一般的な酵素であり、広く特徴づけられた(Viola, R. E. Adv.Enzymol.Relat Areas Mol.Biol 74:295-341(2000))。aspAによってコードされる大腸菌アスパルターゼの結晶構造が解明された(Shiら、Biochemistry 36:9136-9144 (1997))。大腸菌酵素は、代替的な基質のアスパラギン酸フェニルメチルエステル、アスパラギン、ベンジル-アスパラギン酸及びリンゴ酸と反応することも証明された(Maら、Ann N.Y.Acad Sci 672:60-65(1992))。個別の研究において、基質特異性を変化させるために、この酵素に対して指向性進化が採用された(Asanoら、Biomol.Eng 22:95-101(2005))。アスパルターゼ機能性を有する酵素は、ハエモフィルス・インフルエンザエ(Sjostromら、Biochim.Biophys.Acta 1324:182-190(1997))、シュードモナス・フルオレセンス(Takagiら、J.Biochem. 96:545-552(1984))、バシルス・スブチルス(Sjostromら、Biochim.Biophys.Acta 1324:182-190(1997))及びセラチア・マルセセンス(Takagi及びKisumi J Bacteriol. 161:1-6(1985))においても特徴づけられた。
クロストリジウム・アミノブチリウム及びC.クルイベリの両方の4-ヒドロキシブチリル-CoAデヒドラターゼは、4-ヒドロキシブチリル-CoAのクロトニル-CoAへの可逆的変換を触媒し、固有のビニルアセチル-CoAΔ-イソメラーゼ活性を保持する(Scherf及びBuckel Eur.J Biochem. 215:421-429(1993);Scherfら、Arch.Microbiol 161:239-245(1994))。N末端アミノ酸配列を含む両原生酵素が精製され、特徴づけられた(Scherf及びBuckel、前出、1993;Scherfら、前出、1994)。C.アミノブチリウム及びC.クルイベリのabfD遺伝子は、これらのN末端アミノ酸配列と厳密に一致するため、4-ヒドロキシブチリル-CoAデヒドロゲナーゼ/ビニルアセチル-CoAΔイソメラーゼをコードしている。加えて、ポルフィロモナス・ギンギバリスATCC 33277のabfD遺伝子は、ゲノムプロジェクトから相同性を介して特定される。
リシン2,3-アミノムターゼ(EC 5.4.3.2)は、リシンを(3S)-3,6-ジアミノへキサン酸に変換して、アミン基を2位から3位にシフトさせる例示的なアミノムターゼである。該酵素は、フソバクテリウム・ヌレアツム(Fusobacterium nuleatum)(kamA)(Barkerら、J.Bacteriol. 152:201-207(1982))及びクロストリジウム・スブテルミナレ(kamA)(Chirpichら、J.Biol.Chem. 245:1778-1789(1970))を含む、リシンを酢酸及び酪酸に発酵させる細菌に見いだされる。クロストリジウム・スブテルミナレの酵素が結晶化された(Leporeら、Proc.Natl.Acad.Sci.U.S.A 102:13819-13824(2005))。この機能をコードする酵素は、バシルス・スブチルスのyodOによってもコードされる(Chenら、Biochem.J. 348 Pt 3:539-549(2000))。該酵素は、ピリドキサル5'-リン酸を共同因子として利用し、S-アデノシルメトイオニンによる活性化を必要とし、L-リシンのみと反応する立体選択性を有する。該酵素は、代替的な基質と反応することが証明されていない。
例示的な酸-チオールリガーゼは、インビボで可逆的な反応である、1つのATPのコンカミナント消費を伴うコハク酸からのスクシニル-CoAの形成をともに触媒する大腸菌のsucCDの遺伝子生成物である(Buckら、Biochemistry 24(22):p.6245-6252(1985))。さらなる例示的なCoA-リガーゼは、配列がまだ特徴づけられていないラットジカルボン酸-CoAリガーゼ(Vamecqら、Biochem J. 230(3):p. 683-693(1985))、P.クリソゲヌムの2つの特徴づけられたフェニル酢酸-CoAリガーゼ(Lamas-Maceirasら、Biochem J 395(1):147-155(2006);Wangら、Biochem Biophys Res Commun、360(2):453-458(2007))、シュードモナス・プチダのフェニル酢酸-CoAリガーゼ(Martinez-Blancoら、J Biol Chem. 265(12):7084-7090(1990))、及びバシルス・スブチルスの6-カルボキシへキサン酸-CoAリガーゼ(Bowerら、J Bacteriol 178(14):4122-4130(1996))を含む。
(スクシニル-CoAからの例示的なBDO経路)
本実施例では、スクシニル-CoAからの例示的なBDO経路について記載する。
(アルファ-ケトグルタル酸からのさらなる例示的なBDO経路)
本実施例では、アルファ-ケトグルタル酸からのBDO経路について記載する。
(4-アミノ酪酸からのBDO経路)
本実施例では、4-アミノ酪酸からの例示的なBDO経路について記載する。
(アルファ-ケトグルタル酸の例示的なBDO経路)
本実施例では、アルファ-ケトグルタル酸からの例示的なBDO経路について記載する。
(グルタミン酸からの例示的なBDO経路)
本実施例では、グルタル酸からの例示的なBDO経路について記載する。
(アセトアセチル-CoAからの例示的なBDO経路)
本実施例では、アセトアセチル-CoAからの例示的なBDO経路について記載する。
(ホモセリンからの例示的なBDO経路)
本実施例では、ホモセリンからの例示的なBDO経路について記載する。
Claims (21)
該BDO経路が、
(a)アセトアセチル-補酵素A(CoA)の3-ヒドロキシブチリル-CoAへの変換を触媒する3-ヒドロキシブチリル-CoAデヒドロゲナーゼ;
(b)3-ヒドロキシブチリル-CoAのクロトノイル-CoAへの変換を触媒する3-ヒドロキシブチリル-CoAデヒドラターゼ;
(c)クロトノイル-CoAのビニルアセチル-CoAへの変換を触媒するビニルアセチル-CoAΔ-イソメラーゼ;及び
(d)ビニルアセチル-CoAの4-ヒドロキシブチリル-CoAへの変換を触媒する4-ヒドロキシブチリル-CoAデヒドラターゼを含み、更に
(e)4-ヒドロキシブチリル-CoAの1,4-ブタンジオールへの変換を触媒する4-ヒドロキシブチリル-CoAレダクターゼ(アルコール形成)を含むか、又は
4-ヒドロキシブチリル-CoAの4-ヒドロキシブタナールへの変換を触媒する4-ヒドロキシブチリル-CoAレダクターゼ、及び4-ヒドロキシブタナールの1,4-ブタンジオールへの変換を触媒する1,4-ブタンジオールデヒドロゲナーゼを含み、
該微生物体が、
BDO経路酵素(a)3-ヒドロキシブチリル-CoAデヒドロゲナーゼ、(b)3-ヒドロキシブチリル-CoAデヒドラターゼ、(c)ビニルアセチル-CoAΔ-イソメラーゼ、又は(d)4-ヒドロキシブチリル-CoAデヒドラターゼをコードする少なくとも1つの外因性核酸、及び
BDO経路酵素(e)4-ヒドロキシブチリル-CoAレダクターゼ(アルコール形成)、4-ヒドロキシブチリル-CoAレダクターゼ、又は1,4-ブタンジオールデヒドロゲナーゼをコードする少なくとも1つの外因性核酸を含み、
BDOを生成する、前記非天然微生物体。
(e)4-ヒドロキシブチリル-CoAレダクターゼ(アルコール形成)、又は
4-ヒドロキシブチリル-CoAレダクターゼ、及び1,4-ブタンジオールデヒドロゲナーゼ
をコードする外因性核酸を含む、請求項1記載の非天然微生物体。
(e)4-ヒドロキシブチリル-CoAレダクターゼ(アルコール形成)、又は
4-ヒドロキシブチリル-CoAレダクターゼ、及び1,4-ブタンジオールデヒドロゲナーゼ
をコードする外因性核酸を含む、請求項11記載の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19171008P | 2008-09-10 | 2008-09-10 | |
US61/191,710 | 2008-09-10 | ||
US19251108P | 2008-09-17 | 2008-09-17 | |
US61/192,511 | 2008-09-17 | ||
PCT/US2009/056415 WO2010030711A2 (en) | 2008-09-10 | 2009-09-09 | Microorganisms for the production of 1,4-butanediol |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015133621A Division JP2015221043A (ja) | 2008-09-10 | 2015-07-02 | 1,4−ブタンジオールの生成のための微生物体 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012501678A JP2012501678A (ja) | 2012-01-26 |
JP2012501678A5 JP2012501678A5 (ja) | 2014-11-20 |
JP5912529B2 true JP5912529B2 (ja) | 2016-04-27 |
Family
ID=42005726
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011526949A Active JP5912529B2 (ja) | 2008-09-10 | 2009-09-09 | 1,4−ブタンジオールの生成のための微生物体 |
JP2015133621A Pending JP2015221043A (ja) | 2008-09-10 | 2015-07-02 | 1,4−ブタンジオールの生成のための微生物体 |
JP2017122737A Pending JP2017205116A (ja) | 2008-09-10 | 2017-06-23 | 1,4−ブタンジオールの生成のための微生物体 |
JP2019135844A Pending JP2020010685A (ja) | 2008-09-10 | 2019-07-24 | 1,4−ブタンジオールの生成のための微生物体 |
JP2021136782A Pending JP2021192622A (ja) | 2008-09-10 | 2021-08-25 | 1,4−ブタンジオールの生成のための微生物体 |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015133621A Pending JP2015221043A (ja) | 2008-09-10 | 2015-07-02 | 1,4−ブタンジオールの生成のための微生物体 |
JP2017122737A Pending JP2017205116A (ja) | 2008-09-10 | 2017-06-23 | 1,4−ブタンジオールの生成のための微生物体 |
JP2019135844A Pending JP2020010685A (ja) | 2008-09-10 | 2019-07-24 | 1,4−ブタンジオールの生成のための微生物体 |
JP2021136782A Pending JP2021192622A (ja) | 2008-09-10 | 2021-08-25 | 1,4−ブタンジオールの生成のための微生物体 |
Country Status (8)
Country | Link |
---|---|
US (7) | US7858350B2 (ja) |
EP (2) | EP3514242A3 (ja) |
JP (5) | JP5912529B2 (ja) |
AU (1) | AU2009291825B2 (ja) |
BR (1) | BRPI0918483A2 (ja) |
CA (1) | CA2735883C (ja) |
TW (2) | TWI494434B (ja) |
WO (1) | WO2010030711A2 (ja) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0605890D0 (en) * | 2006-03-24 | 2006-05-03 | Bioconversion Technologies Ltd | Enhancemeny Of Microbial Ethanol Production |
CA2678946C (en) | 2007-03-16 | 2019-02-12 | Genomatica, Inc. | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
AU2008307381B2 (en) | 2007-08-10 | 2014-02-20 | Genomatica, Inc. | Methods for the synthesis of acrylic acid and derivatives from fumaric acid |
US7947483B2 (en) | 2007-08-10 | 2011-05-24 | Genomatica, Inc. | Methods and organisms for the growth-coupled production of 1,4-butanediol |
US7803589B2 (en) | 2008-01-22 | 2010-09-28 | Genomatica, Inc. | Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
CA2725549A1 (en) | 2008-06-17 | 2009-12-23 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of fumarate, malate, and acrylate |
US20110190513A1 (en) * | 2008-07-08 | 2011-08-04 | Lynch Michael D | Methods, compositions and systems for biosynthetic bio-production of 1,4-butanediol |
AU2009291825B2 (en) | 2008-09-10 | 2016-05-05 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol |
US20100184173A1 (en) * | 2008-11-14 | 2010-07-22 | Genomatica, Inc. | Microorganisms for the production of methyl ethyl ketone and 2-butanol |
JP2012511928A (ja) | 2008-12-16 | 2012-05-31 | ゲノマチカ, インク. | 合成ガス及び他の炭素源の有用な製品への変換のための微生物及び方法 |
WO2010127319A2 (en) | 2009-04-30 | 2010-11-04 | Genomatica, Inc. | Organisms for the production of 1,3-butanediol |
EP3392340B1 (en) * | 2009-06-04 | 2022-01-05 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
WO2010141780A1 (en) | 2009-06-04 | 2010-12-09 | Genomatica, Inc. | Process of separating components of a fermentation broth |
WO2010144746A2 (en) | 2009-06-10 | 2010-12-16 | Genomatica, Inc. | Microorganisms and methods for carbon-efficient biosynthesis of mek and 2-butanol |
US8715971B2 (en) * | 2009-09-09 | 2014-05-06 | Genomatica, Inc. | Microorganisms and methods for the co-production of isopropanol and 1,4-butanediol |
EP2488652A4 (en) | 2009-10-13 | 2014-04-09 | Genomatica Inc | MICRO-ORGANISMS FOR THE PREPARATION OF 1,4-BANDANDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCIN AND CORRESPONDING COMPOUNDS, AND CORRESPONDING METHODS |
EP2495328B1 (en) * | 2009-10-29 | 2016-03-30 | Korea Research Institute of Bioscience and Biotechnology | Novel method for producing 3-hydroxypropionic acid from glycerol |
US8530210B2 (en) | 2009-11-25 | 2013-09-10 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
CN102753698A (zh) | 2009-12-10 | 2012-10-24 | 基因组股份公司 | 合成气或其他气态碳源和甲醇转化为1,3-丁二醇的方法和有机体 |
BR112012020299A8 (pt) | 2010-02-11 | 2017-10-03 | Metabolix Inc | Processo para produção de gama-butirolactona |
US8445244B2 (en) | 2010-02-23 | 2013-05-21 | Genomatica, Inc. | Methods for increasing product yields |
US9200288B2 (en) | 2010-04-27 | 2015-12-01 | The Regents Of The University Of California | Production of 1,4-butanediol by recombinant microorganisms |
EP2566969B1 (en) | 2010-05-05 | 2019-09-04 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of butadiene |
EP2503003A1 (en) * | 2011-03-24 | 2012-09-26 | Volker Sieber | Synthetic pathway for the production of alcohols or amines |
MX2013011139A (es) | 2011-04-12 | 2013-10-30 | Procter & Gamble | Envases de barrera flexible derivados de recursos renovables. |
US20140134691A1 (en) * | 2011-05-27 | 2014-05-15 | Novozymes A/S | Microorganisms for n-Propanol Production |
US9155139B2 (en) | 2012-03-09 | 2015-10-06 | Rockwell Automation Technologies, Inc. | LED driver circuits and methods |
WO2013142033A1 (en) * | 2012-03-20 | 2013-09-26 | Metabolix, Inc. | Genetically engineered microorganisms for the production of poly-4-hydroxybutyrate |
WO2013184602A2 (en) * | 2012-06-04 | 2013-12-12 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
KR102023618B1 (ko) | 2012-07-27 | 2019-09-20 | 삼성전자주식회사 | 1,4-bdo 생성능이 개선된 변이 미생물 및 이를 이용한 1,4-bdo의 제조방법 |
KR20140016654A (ko) | 2012-07-30 | 2014-02-10 | 삼성전자주식회사 | 대장균 내에서 1,4-부탄디올의 생합성에 사용되는 효소의 개량과 개선된 유전자를 스크리닝 하는 방법 |
US9493746B2 (en) | 2012-07-30 | 2016-11-15 | Samsung Electronics Co., Ltd. | Enzyme used in biosynthesis of 1, 4-BDO and screening method of the same |
US9657316B2 (en) * | 2012-08-27 | 2017-05-23 | Genomatica, Inc. | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto |
EP2899270A4 (en) * | 2012-09-24 | 2016-07-20 | Showa Denko Kk | PROCESS FOR PREPARING BUTANEDIOL |
US9909150B2 (en) | 2012-11-05 | 2018-03-06 | Genomatica, Inc. | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,2-propanediol, n-propanol, 1,3-propanediol, or glycerol related thereto |
US20150353962A1 (en) * | 2012-11-26 | 2015-12-10 | Showa Denko K.K. | Method of manufacturing 1,4-butanediol and microbe |
US9677096B2 (en) | 2012-12-05 | 2017-06-13 | Showa Denko K.K. | Manufacturing method for 1,4-butanediol, microbe, and gene |
BR112015021885B1 (pt) | 2013-03-15 | 2021-08-17 | Genomatica, Inc | Processo para purificação de 1,4-butanodiol (1,4-bdo) |
TR201904615T4 (tr) | 2013-04-12 | 2019-05-21 | Toray Industries | 1,4-bütandiol üretme prosesi. |
WO2014176186A2 (en) * | 2013-04-22 | 2014-10-30 | William Marsh Rice University | Microbial alkanes from c-1 substrate |
BR112015032655A2 (pt) * | 2013-06-29 | 2017-08-22 | Univ California | Micro-organismo recombinante, sistema livre de células, planta, parte de planta ou célula de planta, produto, método para aumentar biomassa ou produção de óleo em uma planta, e, semente de planta |
KR102113254B1 (ko) | 2013-08-23 | 2020-05-21 | 삼성전자주식회사 | 1,4―bdo 생산을 위한 유전자 스크리닝 방법 |
US10035749B2 (en) | 2013-09-03 | 2018-07-31 | Myriant Corporation | Process for manufacturing acrylic acid, acrylonitrile and 1,4-butanediol from 1,3-propanediol |
EP4296364A2 (en) | 2013-12-03 | 2023-12-27 | Genomatica, Inc. | Microorganisms and methods for improving product yields on methanol using acetyl-coa synthesis |
EP3744830B1 (en) | 2013-12-27 | 2023-11-22 | Genomatica, Inc. | Methods and organisms with increased carbon flux efficiencies |
US10059920B2 (en) | 2014-01-16 | 2018-08-28 | University Of Delaware | Synthetic methylotrophy to liquid fuels and chemicals |
EP3132046B1 (en) | 2014-04-16 | 2019-07-24 | Novamont S.p.A. | Process for the production of 1,4-butanediol |
EP3741865B1 (en) | 2014-09-18 | 2024-03-13 | Genomatica, Inc. | Non-natural microbial organisms with improved energetic efficiency |
WO2016066869A1 (es) | 2014-10-30 | 2016-05-06 | Abengoa Research, S.L. | Catalizador microporoso con encapsulación selectiva de óxidos metálicos útil para producir precursores de butadieno |
WO2016066873A1 (es) | 2014-10-30 | 2016-05-06 | Abengoa Research, S.L. | Óxidos mixtos que comprenden magnesio y boro, y su uso como catalizadores para producir precursores de butadieno |
KR101748930B1 (ko) * | 2015-02-09 | 2017-06-20 | 지에스칼텍스 주식회사 | 다이올 생산용 재조합 미생물 |
US9938542B2 (en) | 2015-02-27 | 2018-04-10 | White Dog Labs, Inc. | Mixotrophic fermentation method for making acetone, isopropanol, butyric acid and other bioproducts, and mixtures thereof |
WO2018067458A1 (en) | 2016-10-03 | 2018-04-12 | The Regents Of The University Of California | Engineered microorganisms for production of commodity chemicals and cellular biomass |
EP3601546A1 (en) | 2017-03-31 | 2020-02-05 | Genomatica, Inc. | Aldehyde dehydrogenase variants and methods of use |
JP7219383B2 (ja) | 2017-11-27 | 2023-02-08 | ノバモント・ソシエタ・ペル・アチオニ | 再生可能資源由来の1,4-ブタンジオールの製造方法及びそれから得られるポリエステル |
US20210079334A1 (en) | 2018-01-30 | 2021-03-18 | Genomatica, Inc. | Fermentation systems and methods with substantially uniform volumetric uptake rate of a reactive gaseous component |
EP3814515A2 (en) | 2018-06-26 | 2021-05-05 | Genomatica, Inc. | Engineered microorganisms with g3p---> 3pg enzyme and/or fructose-1,6-bisphosphatase including those having synthetic or enhanced methylotrophy |
EP3856896A1 (en) | 2018-09-26 | 2021-08-04 | Genomatica, Inc. | Aldehyde dehydrogenase variants and methods of using same |
CN115551873A (zh) * | 2020-03-13 | 2022-12-30 | 帝斯曼知识产权资产管理有限公司 | 调节胃肠道微生物代谢途径和代谢物的方法 |
IT202000013243A1 (it) | 2020-06-04 | 2021-12-04 | Novamont Spa | Processo per la purificazione di una miscela di dioli |
FR3125046B1 (fr) * | 2021-07-09 | 2024-05-10 | Snf Sa | Procédé d’obtention de monomere N-vinylpyrrolidone biosourcé |
IT202100030572A1 (it) | 2021-12-02 | 2023-06-02 | Novamont Spa | 1,3-butandiolo purificato da una miscela di dioli |
WO2023126937A1 (en) * | 2021-12-29 | 2023-07-06 | B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University | Selective separation of ammonium and lactate from cell culture media |
CN116083329A (zh) * | 2022-09-26 | 2023-05-09 | 北京绿色康成生物技术有限公司 | 发酵生产γ-丁内酯或1,4-丁二醇的方法 |
Family Cites Families (158)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1230276A (ja) | 1968-12-09 | 1971-04-28 | ||
JPS4831084B1 (ja) | 1970-09-04 | 1973-09-26 | ||
GB1344557A (en) | 1972-06-23 | 1974-01-23 | Mitsubishi Petrochemical Co | Process for preparing 1,4-butanediol |
DE2455617C3 (de) | 1974-11-23 | 1982-03-18 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von Butandiol und/oder Tetrahydrofuran über die Zwischenstufe des γ-Butyrolactons |
DE2501499A1 (de) | 1975-01-16 | 1976-07-22 | Hoechst Ag | Verfahren zur herstellung von butandiol-(1.4) |
GB1583517A (en) | 1977-05-04 | 1981-01-28 | Jackson J F | Solid bowl decanter centrifuges of the scroll discharge type |
DE2842575A1 (de) | 1977-10-04 | 1979-04-12 | Broadbent & Sons Ltd Thomas | Vollmantel-abklaerzentrifuge |
JPS575693A (en) | 1980-06-13 | 1982-01-12 | Ajinomoto Co Inc | Production of l-arginine through fermentation process |
US4301077A (en) | 1980-12-22 | 1981-11-17 | Standard Oil Company | Process for the manufacture of 1-4-butanediol and tetrahydrofuran |
IT1190783B (it) | 1981-04-29 | 1988-02-24 | Davy Mckee Oil & Chem | Processo per l'idrogenolisi di esteri di acidi carbossilici |
US4652685A (en) | 1985-11-15 | 1987-03-24 | General Electric Company | Hydrogenation of lactones to glycols |
JPS62285779A (ja) * | 1986-06-04 | 1987-12-11 | Chiyoda Chem Eng & Constr Co Ltd | 1,4−ブタンジオ−ル産生バチルス属細菌及びそれを用いる1,4−ブタンジオ−ルの製造方法 |
US5250430A (en) | 1987-06-29 | 1993-10-05 | Massachusetts Institute Of Technology | Polyhydroxyalkanoate polymerase |
US5245023A (en) | 1987-06-29 | 1993-09-14 | Massachusetts Institute Of Technology | Method for producing novel polyester biopolymers |
US4876331A (en) | 1987-08-18 | 1989-10-24 | Mitsubishi Kasei Corporation | Copolyester and process for producing the same |
DE68928956T2 (de) | 1988-04-27 | 1999-07-29 | Daicel Chem | Verfahren zur Herstellung von optisch aktivem 1,3-Butanediol |
US4925608A (en) | 1988-09-27 | 1990-05-15 | Norton Company | Joining of SiC parts by polishing and hipping |
EP0373230B1 (en) | 1988-12-12 | 1993-02-17 | Unilever N.V. | Process for the microbiological preparation of 1,3-propane-diol from glycerol |
US5371002A (en) | 1989-06-07 | 1994-12-06 | James Madison University | Method of production of poly-beta-hydroxyalkanoate copolymers |
EP0482077B1 (en) | 1989-07-10 | 1998-10-21 | Massachusetts Institute Of Technology | Method for producing polyester biopolymers |
GB9011777D0 (en) | 1990-05-25 | 1990-07-18 | Ici Plc | Hv/hb copolymer production |
US5674978A (en) | 1990-09-21 | 1997-10-07 | The Regents Of The University Of California | Peptides derived from glutamic acid decarboxylase |
US6682906B1 (en) | 1990-09-21 | 2004-01-27 | The Regents Of The University Of California | Cloned glutamic acid decarboxylase |
US5475086A (en) | 1990-09-21 | 1995-12-12 | The Regents Of The University Of California | Cloned glutamic acid decarboxylase peptides |
US5998366A (en) | 1990-09-21 | 1999-12-07 | The Regents Of The University Of California | Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders |
GB9108756D0 (en) | 1991-04-24 | 1991-06-12 | Ici Plc | Production of polyalkanoate in plants |
EP0522422A3 (en) | 1991-07-01 | 1993-03-17 | Mitsubishi Kasei Corporation | Process for producing a biodegradable polymer |
GB9115245D0 (en) | 1991-07-16 | 1991-08-28 | Ici Plc | Production of polyalkanoate |
US5610041A (en) | 1991-07-19 | 1997-03-11 | Board Of Trustees Operating Michigan State University | Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants |
EP0595896B1 (en) | 1991-07-19 | 2005-05-18 | Michigan State University | Transgenic plants producing polyhydroxyalkanoates |
BR9203053A (pt) | 1991-08-07 | 1993-03-30 | Ajinomoto Kk | Processo para produzir acido l-glutamico pro fermentacao |
JP2777757B2 (ja) | 1991-09-17 | 1998-07-23 | 鐘淵化学工業株式会社 | 共重合体およびその製造方法 |
DE4220759A1 (de) | 1992-06-24 | 1994-01-05 | Inst Genbiologische Forschung | DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers |
GB9223332D0 (en) | 1992-11-06 | 1992-12-23 | Ici Plc | Production of polyhydroxyalkanoate in plants |
CA2127807A1 (en) | 1992-11-20 | 1994-06-09 | John Maliyakal | Transgenic cotton plants producing heterologous bioplastic |
JP3263710B2 (ja) | 1992-12-11 | 2002-03-11 | 高砂香料工業株式会社 | 生分解性光学活性ポリマー及びその製造方法 |
JP3241505B2 (ja) | 1993-08-11 | 2001-12-25 | 高砂香料工業株式会社 | 生分解性光学活性コポリマー及びその製造方法 |
CA2175042C (en) | 1993-10-28 | 2002-05-28 | Hiroyuki Kojima | Method for production of substances using microorganisms with an increased productivity for nadph |
GB9414506D0 (en) | 1994-07-18 | 1994-09-07 | Zeneca Ltd | Improved production of polyhydroxyalkanoate |
DE4433134A1 (de) | 1994-09-16 | 1996-03-21 | Buck Chem Tech Werke | Verfahren zur Herstellung von Polyhydroxyfettsäuren sowie rekombinanter Bakterienstämme zur Durchführung des Verfahrens |
US5563239A (en) | 1994-11-09 | 1996-10-08 | Eastman Chemical Company | Composition and process for the production of poly(3-hydroxyalkanoates) |
US5478952A (en) | 1995-03-03 | 1995-12-26 | E. I. Du Pont De Nemours And Company | Ru,Re/carbon catalyst for hydrogenation in aqueous solution |
US5747311A (en) | 1995-08-22 | 1998-05-05 | Microgen Corporation | Process for chemical modification of reactants by microbes |
US5869301A (en) | 1995-11-02 | 1999-02-09 | Lockhead Martin Energy Research Corporation | Method for the production of dicarboxylic acids |
US5770435A (en) | 1995-11-02 | 1998-06-23 | University Of Chicago | Mutant E. coli strain with increased succinic acid production |
DE19543635A1 (de) | 1995-11-23 | 1997-05-28 | Hp Chemie Pelzer Res & Dev | Verbundwerkstoffe aus Polyhydroxyfettsäuren und Fasermaterialien |
US5849894A (en) | 1995-11-29 | 1998-12-15 | Monsanto Company | Rhodospirillum rubrum poly-β-hydroxyalkanoate synthase |
WO1997032012A1 (en) | 1996-02-27 | 1997-09-04 | Michigan State University | Cloning and expression of the gene encoding thermoanaerobacter ethanolicus 39e secondary-alcohol dehydrogenase and enzyme biochemical characterization |
US5959179A (en) | 1996-03-13 | 1999-09-28 | Monsanto Company | Method for transforming soybeans |
US5958745A (en) | 1996-03-13 | 1999-09-28 | Monsanto Company | Methods of optimizing substrate pools and biosynthesis of poly-β-hydroxybutyrate-co-poly-β-hydroxyvalerate in bacteria and plants |
US6091002A (en) | 1996-03-13 | 2000-07-18 | Monsanto Company | Polyhydroxyalkanoates of narrow molecular weight distribution prepared in transgenic plants |
US5750848A (en) | 1996-08-13 | 1998-05-12 | Monsanto Company | DNA sequence useful for the production of polyhydroxyalkanoates |
US6730503B1 (en) | 1996-09-19 | 2004-05-04 | Roche Vitamins Inc. | Alcohol/aldehyde dehydrogenase |
JPH10166664A (ja) | 1996-12-12 | 1998-06-23 | Casio Electron Mfg Co Ltd | カラー印刷装置 |
WO1998036078A1 (en) | 1997-02-13 | 1998-08-20 | James Madison University | Methods of making polyhydroxyalkanoates comprising 4-hydroxybutyrate monomer units |
US6759219B2 (en) | 1997-03-03 | 2004-07-06 | Metabolix, Inc. | Methods for the biosynthesis of polyesters |
ATE364709T1 (de) | 1997-04-21 | 2007-07-15 | Metabolix Inc | Endstellige hydroxyl aufweisende polyhydroxyalkanoate |
US6156852A (en) | 1997-04-21 | 2000-12-05 | Monsanto Company | Hydroxy-terminated polyhydroxyalkanoates |
KR19990013007A (ko) | 1997-07-31 | 1999-02-25 | 박원훈 | 형질전환된 대장균 ss373(kctc 8818p)과 이를 이용한숙신산의 생산방법 |
DE69838768T2 (de) | 1997-09-19 | 2008-10-30 | Metabolix, Inc., Cambridge | Biologische Systeme zur Herstellung von Polyhydroxyalkanoat-Polymeren die 4-Hy droxysäure enthalten |
US6228579B1 (en) | 1997-11-14 | 2001-05-08 | San Diego State University Foundation | Method for identifying microbial proliferation genes |
US6280986B1 (en) | 1997-12-01 | 2001-08-28 | The United States Of America As Represented By The Secretary Of Agriculture | Stabilization of pet operon plasmids and ethanol production in bacterial strains lacking lactate dehydrogenase and pyruvate formate lyase activities |
US6159738A (en) | 1998-04-28 | 2000-12-12 | University Of Chicago | Method for construction of bacterial strains with increased succinic acid production |
AU5101599A (en) | 1998-07-15 | 2000-02-07 | E.I. Du Pont De Nemours And Company | Tetrahydrofolate metabolism enzymes |
WO2000008198A1 (en) | 1998-08-04 | 2000-02-17 | Metabolix, Inc. | Polyhydroxyalkanoate production from polyols |
AU753132B2 (en) | 1998-08-18 | 2002-10-10 | Metabolix, Inc. | Transgenic microbial polyhydroxyalkanoate producers |
US6835820B2 (en) | 1999-01-07 | 2004-12-28 | The University Of Massachusetts | Polyhydroxyalkanoate biosynthesis associated proteins and coding region in bacillus megaterium |
AU3482200A (en) | 1999-02-02 | 2000-08-25 | Bernhard Palsson | Methods for identifying drug targets based on genomic sequence data |
US6686310B1 (en) | 1999-02-09 | 2004-02-03 | E. I. Du Pont De Nemours And Company | High surface area sol-gel route prepared hydrogenation catalysts |
US6448473B1 (en) | 1999-03-05 | 2002-09-10 | Monsanto Technology Llc | Multigene expression vectors for the biosynthesis of products via multienzyme biological pathways |
WO2000061763A2 (en) * | 1999-04-09 | 2000-10-19 | University Of Guelph | Proteins related to gaba metabolism |
KR100329019B1 (ko) | 1999-04-13 | 2002-03-18 | 윤덕용 | 유기산의 고효율 생산방법 |
CA2733616C (en) | 1999-08-18 | 2016-09-27 | E.I. Du Pont De Nemours And Company | Process for the biological production of 1,3-propanediol with high titer |
US6361983B1 (en) * | 1999-09-30 | 2002-03-26 | E. I. Du Pont De Nemours And Company | Process for the isolation of 1,3-propanediol from fermentation broth |
DE19956686A1 (de) | 1999-11-25 | 2001-05-31 | Degussa | Neue für die Gene sucC und sucD codierende Nukleotidsequenzen |
US6897055B2 (en) | 1999-11-25 | 2005-05-24 | Degussa Ag | Nucleotide sequences coding for the genes sucC and sucD |
EP1275674B1 (en) * | 2000-04-21 | 2007-04-04 | Mitsubishi Rayon Co., Ltd. | Epoxy resin composition and prepreg made with the epoxy resin composition |
EP1305439B1 (en) | 2000-07-21 | 2006-06-07 | Metabolix, Inc. | Production of polyhydroxyalkanoates from polyols |
US6495152B2 (en) | 2000-08-18 | 2002-12-17 | Tepha, Inc. | Sulfur containing polyhydroxyalkanoate compositions and method of production |
US6916637B2 (en) | 2000-09-30 | 2005-07-12 | Degussa Ag | Fermentation process for the preparation of L-amino acids using strains of the family Enterobacteriaceae |
AU1981802A (en) | 2000-11-20 | 2002-06-03 | Cargill Inc | 3-hydroxypropionic acid and other organic compounds |
WO2002053746A1 (en) | 2000-12-28 | 2002-07-11 | Toyota Jidosha Kabushiki Kaisha | Process for producing prenyl alcohol |
US7711490B2 (en) | 2001-01-10 | 2010-05-04 | The Penn State Research Foundation | Method and system for modeling cellular metabolism |
US7127379B2 (en) | 2001-01-31 | 2006-10-24 | The Regents Of The University Of California | Method for the evolutionary design of biochemical reaction networks |
JP2004533037A (ja) | 2001-03-01 | 2004-10-28 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 調節された反応ネットワークの全体的特性を決定するためのモデルおよび方法 |
US7052883B2 (en) | 2001-04-03 | 2006-05-30 | Degussa Ag | Process for the production of L-amino acids using strains of the family Enterobacteriaceae that contain an attenuated fruR gene |
AU2002314203A1 (en) | 2001-07-18 | 2003-03-03 | Degussa Ag | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene |
US20090158452A1 (en) * | 2001-12-04 | 2009-06-18 | Johnson Richard G | Transgenic plants with enhanced agronomic traits |
US20090100536A1 (en) * | 2001-12-04 | 2009-04-16 | Monsanto Company | Transgenic plants with enhanced agronomic traits |
CN1217001C (zh) | 2002-01-04 | 2005-08-31 | 清华大学 | 一种生产d-(-)-3-羟基丁酸的方法 |
US7309597B2 (en) | 2002-01-18 | 2007-12-18 | Cargill, Incorporated | Alanine 2,3-Aminomutase |
US7314974B2 (en) | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
US20030224363A1 (en) | 2002-03-19 | 2003-12-04 | Park Sung M. | Compositions and methods for modeling bacillus subtilis metabolism |
AU2003222128A1 (en) | 2002-03-29 | 2003-10-13 | Genomatica, Inc. | Human metabolic models and methods |
WO2003095651A1 (fr) | 2002-05-10 | 2003-11-20 | Kyowa Hakko Kogyo Co., Ltd. | Procede de production d'acide mevalonique |
US7856317B2 (en) | 2002-06-14 | 2010-12-21 | Genomatica, Inc. | Systems and methods for constructing genomic-based phenotypic models |
US8027821B2 (en) | 2002-07-10 | 2011-09-27 | The Penn State Research Foundation | Method for determining gene knockouts |
US7413878B2 (en) | 2002-07-15 | 2008-08-19 | Kosan Biosciences, Inc. | Recombinant host cells expressing atoAD and capable of making a polyketide using a starter unit |
AU2003258187A1 (en) | 2002-08-09 | 2004-02-25 | Codexis, Inc. | Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives |
US8071355B2 (en) | 2002-09-12 | 2011-12-06 | Metabolix, Inc. | Polyhydroxyalkanoate production by coenzyme A-dependent aldehyde dehydrogenase pathways |
JP4528624B2 (ja) | 2002-09-27 | 2010-08-18 | ディーエスエム アイピー アセッツ ビー.ブイ. | アルデヒドデヒドロゲナーゼ遺伝子 |
JP5064656B2 (ja) | 2002-10-15 | 2012-10-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 実施反応経路を同定するための方法およびシステム |
US20040152159A1 (en) | 2002-11-06 | 2004-08-05 | Causey Thomas B. | Materials and methods for the efficient production of acetate and other products |
AU2004266100A1 (en) | 2003-08-11 | 2005-03-03 | Codexis, Inc. | Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
US7927859B2 (en) | 2003-08-22 | 2011-04-19 | Rice University | High molar succinate yield bacteria by increasing the intracellular NADH availability |
WO2005026338A1 (en) | 2003-09-18 | 2005-03-24 | Ciba Specialty Chemicals Holding Inc. | Alcohol dehydrogenases with increased solvent and temperature stability |
US7470530B2 (en) * | 2003-11-27 | 2008-12-30 | Korea Advanced Institute Of Science And Technology | Rumen bacteria variants and process for preparing succinic acid employing the same |
FR2864967B1 (fr) | 2004-01-12 | 2006-05-19 | Metabolic Explorer Sa | Microorganisme evolue pour la production de 1,2-propanediol |
DE102004031177A1 (de) * | 2004-06-29 | 2006-01-19 | Henkel Kgaa | Neue Geruchsstoffe bildende Genprodukte von Bacillus licheniformis und darauf aufbauende verbesserte biotechnologische Produktionsverfahren |
KR100656590B1 (ko) | 2004-07-30 | 2006-12-11 | 한국과학기술원 | 박테리아 변이균주 및 이를 이용한 숙신산 및 아미노산의제조방법 |
US7601858B2 (en) * | 2004-08-17 | 2009-10-13 | Gs Cleantech Corporation | Method of processing ethanol byproducts and related subsystems |
EP3130676A1 (en) | 2004-08-27 | 2017-02-15 | Rice University | Mutant e. coli strain with increased succinic acid production |
GB0419424D0 (en) * | 2004-09-02 | 2004-10-06 | Viragen Scotland Ltd | Transgene optimisation |
EP2434015B1 (en) | 2004-09-09 | 2013-11-20 | Research Institute Of Innovative Technology For The Earth | DNA fragment having promoter function |
US7569380B2 (en) | 2004-12-22 | 2009-08-04 | Rice University | Simultaneous anaerobic production of isoamyl acetate and succinic acid |
KR100727054B1 (ko) | 2005-08-19 | 2007-06-12 | 한국과학기술원 | 푸마레이트 하이드라타제 c를 코딩하는 유전자로 형질전환된 재조합 미생물 및 이를 이용한 숙신산의 제조방법 |
KR100679638B1 (ko) | 2005-08-19 | 2007-02-06 | 한국과학기술원 | 포메이트 디하이드로게나제 d 또는 e를 코딩하는 유전자로 형질전환된 미생물 및 이를 이용한 숙신산의 제조방법 |
KR100676160B1 (ko) | 2005-08-19 | 2007-02-01 | 한국과학기술원 | 말릭효소를 코딩하는 유전자로 형질전환된 재조합 미생물 및 이를 이용한 숙신산의 제조방법 |
US20070111294A1 (en) | 2005-09-09 | 2007-05-17 | Genomatica, Inc. | Methods and organisms for the growth-coupled production of succinate |
US9297028B2 (en) | 2005-09-29 | 2016-03-29 | Butamax Advanced Biofuels Llc | Fermentive production of four carbon alcohols |
US20080274526A1 (en) | 2007-05-02 | 2008-11-06 | Bramucci Michael G | Method for the production of isobutanol |
KR20070096348A (ko) * | 2006-03-23 | 2007-10-02 | 주식회사 엘지화학 | 1,4―butanediol〔1,4―BDO〕생성능을가지는 변이체 및 이를 이용한 1,4―BDO의 제조방법 |
NZ600540A (en) | 2006-05-01 | 2013-12-20 | Univ Florida | Ethanol production in non-recombinant hosts |
US8206970B2 (en) | 2006-05-02 | 2012-06-26 | Butamax(Tm) Advanced Biofuels Llc | Production of 2-butanol and 2-butanone employing aminobutanol phosphate phospholyase |
DE102006025821A1 (de) | 2006-06-02 | 2007-12-06 | Degussa Gmbh | Ein Enzym zur Herstellung von Mehylmalonatsemialdehyd oder Malonatsemialdehyd |
WO2008027742A1 (en) | 2006-08-30 | 2008-03-06 | Cargill, Incorporated | Beta-alanine/alpha-ketoglutarate aminotransferase for 3-hydroxypropionic acid production |
US8017364B2 (en) | 2006-12-12 | 2011-09-13 | Butamax(Tm) Advanced Biofuels Llc | Solvent tolerant microorganisms |
CA2678946C (en) | 2007-03-16 | 2019-02-12 | Genomatica, Inc. | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
CN101688196B (zh) * | 2007-03-20 | 2015-01-07 | 佛罗里达大学研究基金公司 | 用于有效生产琥珀酸和苹果酸的材料和方法 |
US7910342B2 (en) | 2007-04-18 | 2011-03-22 | Butamax(Tm) Advanced Biofuels Llc | Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes |
EP2147111A4 (en) | 2007-04-18 | 2010-06-23 | Gevo Inc | MANIPULATED MICROORGANISMS FOR THE MANUFACTURE OF ISOPROPANOL |
US8426174B2 (en) | 2007-05-02 | 2013-04-23 | Butamax(Tm) Advanced Biofuels Llc | Method for the production of 2-butanol |
US8426173B2 (en) | 2007-05-02 | 2013-04-23 | Butamax (Tm) Advanced Biofuels Llc | Method for the production of 1-butanol |
US20110039327A1 (en) | 2007-05-18 | 2011-02-17 | Aaron Adriaan Winkler | Organic acid production by fungal cells |
EP2155885A4 (en) | 2007-05-18 | 2010-12-01 | Microbia Prec Engineering Inc | ACIDIC ACID PRODUCTION IN RECOMBINANT YEAST |
US20090023182A1 (en) * | 2007-07-18 | 2009-01-22 | Schilling Christophe H | Complementary metabolizing organisms and methods of making same |
US7947483B2 (en) | 2007-08-10 | 2011-05-24 | Genomatica, Inc. | Methods and organisms for the growth-coupled production of 1,4-butanediol |
KR101042242B1 (ko) | 2007-09-07 | 2011-06-17 | 한국과학기술원 | 1,4-부탄디올 생성능을 가지는 변이체 및 이를 이용한1,4-부탄디올의 제조방법 |
US20100221800A1 (en) | 2007-10-12 | 2010-09-02 | The Regents Of The University Of California | Microorganism engineered to produce isopropanol |
US7803589B2 (en) | 2008-01-22 | 2010-09-28 | Genomatica, Inc. | Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
WO2009103026A1 (en) | 2008-02-15 | 2009-08-20 | Gevo, Inc. | Engineered microorganisms for producing isopropanol |
US20090246842A1 (en) | 2008-02-15 | 2009-10-01 | Gevo, Inc. | Engineered microorganisms for producing propanol |
WO2009111513A1 (en) | 2008-03-03 | 2009-09-11 | Joule Biotechnologies, Inc. | Engineered co2 fixing microorganisms producing carbon-based products of interest |
JP5395063B2 (ja) | 2008-04-25 | 2014-01-22 | 公益財団法人地球環境産業技術研究機構 | イソプロパノール生産能を有するコリネ型細菌の形質転換体 |
JP2011519561A (ja) | 2008-05-01 | 2011-07-14 | ジェノマティカ, インコーポレイテッド | メタクリル酸の産生のための微生物 |
US20110190513A1 (en) * | 2008-07-08 | 2011-08-04 | Lynch Michael D | Methods, compositions and systems for biosynthetic bio-production of 1,4-butanediol |
AU2009291825B2 (en) * | 2008-09-10 | 2016-05-05 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol |
US8344188B2 (en) | 2008-10-16 | 2013-01-01 | Maverick Biofuels, Inc. | Methods and apparatus for synthesis of alcohols from syngas |
JP2012511928A (ja) | 2008-12-16 | 2012-05-31 | ゲノマチカ, インク. | 合成ガス及び他の炭素源の有用な製品への変換のための微生物及び方法 |
US20110014669A1 (en) | 2009-01-23 | 2011-01-20 | Microbia, Inc. | Production of 1,4 Butanediol in a Microorganism |
WO2010141780A1 (en) | 2009-06-04 | 2010-12-09 | Genomatica, Inc. | Process of separating components of a fermentation broth |
EP3392340B1 (en) * | 2009-06-04 | 2022-01-05 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
US8715971B2 (en) | 2009-09-09 | 2014-05-06 | Genomatica, Inc. | Microorganisms and methods for the co-production of isopropanol and 1,4-butanediol |
EP2488652A4 (en) | 2009-10-13 | 2014-04-09 | Genomatica Inc | MICRO-ORGANISMS FOR THE PREPARATION OF 1,4-BANDANDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCIN AND CORRESPONDING COMPOUNDS, AND CORRESPONDING METHODS |
US8530210B2 (en) | 2009-11-25 | 2013-09-10 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
CN102753698A (zh) * | 2009-12-10 | 2012-10-24 | 基因组股份公司 | 合成气或其他气态碳源和甲醇转化为1,3-丁二醇的方法和有机体 |
US8048661B2 (en) | 2010-02-23 | 2011-11-01 | Genomatica, Inc. | Microbial organisms comprising exogenous nucleic acids encoding reductive TCA pathway enzymes |
US8445244B2 (en) | 2010-02-23 | 2013-05-21 | Genomatica, Inc. | Methods for increasing product yields |
-
2009
- 2009-09-09 AU AU2009291825A patent/AU2009291825B2/en active Active
- 2009-09-09 CA CA2735883A patent/CA2735883C/en active Active
- 2009-09-09 US US12/556,550 patent/US7858350B2/en active Active
- 2009-09-09 WO PCT/US2009/056415 patent/WO2010030711A2/en active Application Filing
- 2009-09-09 EP EP18214553.2A patent/EP3514242A3/en active Pending
- 2009-09-09 JP JP2011526949A patent/JP5912529B2/ja active Active
- 2009-09-09 BR BRPI0918483-0A patent/BRPI0918483A2/pt not_active Application Discontinuation
- 2009-09-09 EP EP09813563.5A patent/EP2334800B1/en active Active
- 2009-09-10 TW TW098130590A patent/TWI494434B/zh active
- 2009-09-10 TW TW104113976A patent/TW201529856A/zh unknown
-
2010
- 2010-11-16 US US12/947,790 patent/US8129156B2/en active Active
-
2011
- 2011-01-19 US US13/009,813 patent/US8178327B2/en active Active
-
2012
- 2012-04-17 US US13/449,187 patent/US9175297B2/en active Active
- 2012-08-03 US US13/566,826 patent/US20130071886A1/en not_active Abandoned
-
2015
- 2015-04-29 US US14/700,096 patent/US20160053287A1/en not_active Abandoned
- 2015-07-02 JP JP2015133621A patent/JP2015221043A/ja active Pending
-
2017
- 2017-06-23 JP JP2017122737A patent/JP2017205116A/ja active Pending
- 2017-08-21 US US15/682,349 patent/US20180142269A1/en not_active Abandoned
-
2019
- 2019-07-24 JP JP2019135844A patent/JP2020010685A/ja active Pending
-
2021
- 2021-08-25 JP JP2021136782A patent/JP2021192622A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2010030711A3 (en) | 2010-10-07 |
TW201529856A (zh) | 2015-08-01 |
AU2009291825B2 (en) | 2016-05-05 |
US20110159572A1 (en) | 2011-06-30 |
EP2334800B1 (en) | 2018-12-26 |
JP2015221043A (ja) | 2015-12-10 |
TW201016854A (en) | 2010-05-01 |
BRPI0918483A2 (pt) | 2020-07-14 |
EP2334800A2 (en) | 2011-06-22 |
US8178327B2 (en) | 2012-05-15 |
US20180142269A1 (en) | 2018-05-24 |
WO2010030711A2 (en) | 2010-03-18 |
US20130109069A1 (en) | 2013-05-02 |
AU2009291825A1 (en) | 2010-03-18 |
US20130071886A1 (en) | 2013-03-21 |
CA2735883C (en) | 2020-05-05 |
US20160053287A1 (en) | 2016-02-25 |
JP2020010685A (ja) | 2020-01-23 |
US20100112654A1 (en) | 2010-05-06 |
TWI494434B (zh) | 2015-08-01 |
JP2012501678A (ja) | 2012-01-26 |
EP3514242A3 (en) | 2019-08-28 |
CA2735883A1 (en) | 2010-03-18 |
US9175297B2 (en) | 2015-11-03 |
US20110281337A1 (en) | 2011-11-17 |
JP2017205116A (ja) | 2017-11-24 |
EP2334800A4 (en) | 2012-08-22 |
US8129156B2 (en) | 2012-03-06 |
JP2021192622A (ja) | 2021-12-23 |
US7858350B2 (en) | 2010-12-28 |
EP3514242A2 (en) | 2019-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5912529B2 (ja) | 1,4−ブタンジオールの生成のための微生物体 | |
US11401534B2 (en) | Microorganisms for the production of 1,4- butanediol and related methods | |
JP2013507145A (ja) | 1,4−ブタンジオール、4−ヒドロキシブタナール、4−ヒドロキシブチリル−CoA、プトレシン及び関連化合物の生成のための微生物体並びに関連する方法 | |
AU2013203480A1 (en) | Microorganisms for the production of 1,4-butanediol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120905 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120905 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140401 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140625 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140702 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20140930 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20141001 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150303 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150702 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20150727 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20150717 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150818 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20151113 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160216 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160308 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160401 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5912529 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |